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Abstract
Mitochondrial calcium (Ca2+) uptake plays fundamental roles in various signaling
processes. Entry of Ca2+ into the mitochondrial matrix is tightly controlled by the
mitochondrial Ca2+ uniporter (MCU) in a higher order complex regulated by inter- and
intra-molecular protein-protein interactions. However, the precise mechanisms controlling
MCU function and regulation remain largely unknown. I identified a well-folded Nterminal MCU region from residues 72-189, and its crystal structure revealed a β-grasplike fold with a cluster of acidic residues that facilitates interactions with dibasic cations.
Binding of Ca2+ or Mg2+ destabilize this fold and shift the protein towards monomer. Single
mutants disrupting the acidic face reduced the cation sensitivity in vitro. Together, my data
reveal that the β-grasp-like matrix region of MCU harbors a distinct acidic patch that
modulates stability and protein-protein interaction equilibria in response to Mg2+ and Ca2+
binding, suggesting that these matrix cations play an important role in controlling MCU
activity.
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Chapter 1

Introduction
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1.1

The general framework of cellular calcium (Ca2+) regulation and signaling

In all eukaryotic cells, the Ca2+ concentration ([Ca2+]) of the cytosol is tightly controlled by
complex interactions among binding proteins, channels, exchangers and pumps (Rizzuto et
al., 2009). The cytosolic [Ca2+] is maintained around 100 nM in resting conditions, which
is significantly lower than the extracellular [Ca2+] of approximately 1 mM. This is
maintained by the low permeability of the plasma membrane to ions and the activity of the
plasma membrane Ca2+-ATPase and the Na+/Ca2+ exchanger (NCX) (Rizzuto et al., 2009).
This precise regulation allows Ca2+ to be one of the most important second messengers in
signal transduction pathways (Hajnoczky et al., 2000b; Hajnoczky et al., 2002).
There are two fundamental mechanisms through which intracellular [Ca2+] can be increased.
The first involves Ca2+ release from intracellular stores, mainly the endoplasmic reticulum
(ER) and Golgi apparatus, and the second mechanism involves the entry of Ca2+ from the
extracellular space (Rizzuto et al., 2009). Ca2+ release from intracellular stores is mainly
induced by inositol 1,4,5-trisphosphate receptor (IP3R), a transmembrane (TM) protein
located on the ER and Golgi membrane. When extracellular soluble agonists bind a Gprotein-coupled receptor, inositol 1,4,5-trisphosphate (IP3) is produced by activation of
phospholipase C (Rizzuto et al., 2009). IP3 binding to its receptor induces opening and
release of Ca2+ from the ER and Golgi apparatus. If the opening of the IP3R causes a
depletion of ER Ca2+ stores, plasma membrane Ca2+ channels are activated and mediate
Ca2+ entry from the extracellular space, in a process named the store-operated Ca2+ entry
(Rizzuto et al., 2009). An ER Ca2+-sensing protein called stromal interaction molecule and
specialized Ca2+ channels in the plasma membrane made up of Orai1 protein subunits have
been identified in the last few years as key molecular determinants of store-operated Ca2+
entry (Oh-hora & Rao, 2008).
The second mechanism inducing increased intracellular Ca2+ involves the opening of
plasma membrane Ca2+ channels, which are grouped into three classes: the voltageoperated Ca2+ channels, opened by a decrease in membrane potential (Bertolino & Llinas,
1992), the receptor-operated Ca2+ channels such as vanilloid receptor subtype 1, opened by
capsaicin (Jambrina et al., 2003), and the second messenger-operated channels, opened by
the binding of a second messenger on the inner surface of the membrane (Meldolesi &
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Pozzan, 1987). In the case of second messenger-operated channels, second messengers
such as diacylglycerols interact with and initiate activation of the channels (Clementi &
Meldolesi, 1996).
To restore resting conditions, Ca2+ must be rapidly removed from the cytosol once
downstream targets are activated. Therefore, in addition to induced increases in
intracellular Ca2+, there are also Ca2+ extrusion mechanisms (O'Neill et al., 2016; Rizzuto
et al., 2009; van Loon et al., 2016; Wolwer et al., 2016). Plasma membrane Ca2+-ATPase
for example, is a transport protein in the plasma membrane of cells that removes
intracellular Ca2+ (Boczek et al., 2014). This transporter is driven by the hydrolysis of
adenosine triphosphate (ATP), with one Ca2+ removed for each molecule of ATP
hydrolyzed (Oceandy et al., 2007). Another example of a transporter involved in Ca2+
extrusion is NCX, an antiporter membrane protein that also removes intracellular Ca2+.
NCX uses stored energy in the electrochemical gradient of Na+ by allowing Na+ to flow
down its gradient across the plasma membrane in exchange for Ca2+, removing one Ca2+ in
exchange for the import of three Na+ (Yu & Choi, 1997). Organelle uptake of Ca2+ is
involved in returning Ca2+ levels to basal in the cytosol (Becker et al., 1980; Clapham,
2007) and hence, it is important for cells to have homeostatic balance of influx and efflux
of intracellular Ca2+ in order to function properly.

1.2

Discovery of mitochondrial Ca2+ uptake

Mitochondrial Ca2+ uptake was first measured over 50 years ago, when studies showed that
mitochondria were capable of rapid Ca2+ uptake (Deluca & Engstrom, 1961; Rossi &
Lehninger, 1964). This rapid Ca2+ uptake increased mitochondrial matrix Ca2+
concentrations by factors of 10 or more. The ability of isolated mitochondria to accumulate
Ca2+ led to suggestions in the late 1970s that mitochondria may be involved in regulating
cytosolic Ca2+. It was found that if extra-mitochondrial Ca2+ was increased above a certain
set point, mitochondria would accumulate Ca2+, whereas if extra-mitochondrial Ca2+ was
reduced below this set point, mitochondria would release Ca2+ via the efflux pathway
(Nicholls, 1978).
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Attention returned to mitochondria a couple of decades later with the development of highly
specific probes that revealed microdomains of high Ca2+ concentrations close to the
mitochondria (Hajnoczky et al., 1995; Rudolf et al., 2004). Mitochondria close to these
microdomains of high Ca2+ concentration are able to rapidly take up Ca2+. Therefore, it was
speculated that Ca2+ release from the ER exposed mitochondria to much higher Ca2+
concentrations than what is usually present in the cytosol (Marsault et al., 1997; Rizzuto et
al., 1993). Furthermore, mitochondria appear to be bound to the ER at designated signaling
sites, allowing their close proximity and ability to use these small, locally potent (high
concentration) releases of Ca2+ (de Brito & Scorrano, 2008). If the proximity between the
ER and mitochondria are shortened, mitochondria are more prone to Ca2+ overload, due to
their increased exposure to microdomains of high cytosolic Ca2+ (Dorn & Scorrano, 2010).
Collectively, it is evident that mitochondria are responsible for Ca2+ uptake in cells and
involved in the regulation of cytosolic Ca2+.

1.3

Importance of mitochondrial Ca2+ uptake

Balanced Ca2+ uptake by the mitochondria is essential for cells and important for energy
production, buffering and shaping cytosolic Ca2+ rises and also in determining cell fate by
triggering or preventing apoptosis (Saris & Carafoli, 2005). Therefore, mitochondrial Ca2+
levels can stimulate important metabolic processes at appropriate levels. Mitochondria are
known as the powerhouse of the cell and are able to produce ATP and maintain an inner
membrane potential. In fact, Ca2+ activates three mitochondrial matrix dehydrogenases
essential for ATP production (Denton, 2009), in addition to several complexes of the
electron transport chain (Glancy & Balaban, 2012). The activation of the three
dehydrogenases by Ca2+ increases nicotinamide adenine dinucleotide availability, resulting
in increased flow of electrons down the respiratory chain leading to increased ATP
production for the cell (Territo et al., 2000). However, excessive mitochondrial Ca2+ can
be detrimental for a cell, activating cell death pathways such as apoptosis and necrosis
(Raffaello et al., 2013). Mitochondria are capable of rapidly taking up Ca2+, but at excessive
levels, their ability to balance Ca2+ can be overwhelmed. When this occurs, pathological
Ca2+ concentrations are reached and a large conductance channel known as the
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mitochondrial permeability transition pore (mPTP) opens in the inner mitochondrial
membrane (IMM) (Baines, 2009; Di Lisa et al., 2011; Halestrap, 2009). This pore is
implicated in multiple cell death pathways, including cardiac and neuronal death,
hepatotoxicity, and nervous and muscular dystrophies (Hunter et al., 1976). Upon mPTP
opening due to mitochondrial Ca2+ overload, the mitochondrial membrane potential
collapses which disrupts the cell’s energy production mechanism, resulting in
mitochondrial swelling and ultimately cell death (Juhaszova et al., 2008). Opening of the
mPTP may also lead to the release of caspase cofactors into the cytoplasm which triggers
apoptosis (Rizzuto et al., 2012). Fortunately, in cell death caused by mPTP opening,
blocking of either the mPTP or the reduction of mitochondrial Ca2+ uptake seem to be
protective, suggesting that mitochondrial Ca2+ uptake may be a potential target for
therapeutic intervention (Baines et al., 2005; Griffiths & Halestrap, 1993). Therefore, it is
clear that mechanisms for altering mitochondrial Ca2+ levels, and maintaining homeostasis,
are essential for both aerobic metabolism and cell survival.

1.4

Identification of the mitochondrial Ca2+ uniporter (MCU)

Although it was clear for decades that Ca2+ was taken up by the mitochondria and involved
in the regulation of processes such as aerobic metabolism and cell death, the actual protein
responsible for taking up Ca2+ was not identified until 2011 (Harrington & Murphy, 2015).
In 2010, a mitochondrial protein that bound Ca2+ known as the mitochondrial Ca2+ uptake
1 (MICU1) was identified in silico in the MitoCarta database, which is an inventory of 1158
human and mouse genes encoding proteins with strong support of mitochondrial
localization (Calvo et al., 2016; Perocchi et al., 2010). MICU1 seemed to be necessary for
rapid mitochondrial Ca2+ uptake in intact cells and when silenced, diminished
mitochondrial Ca2+ uptake (De Stefani et al., 2011). However, it was correctly
hypothesized that MICU1 was more likely to be a regulator of a uniporter rather than a core
component, since it had maximally only one predicted TM domain, while a pore would
need at least two (Harrington & Murphy, 2015). It was also noted that due to its two EF
hands with the ability to bind Ca2+, MICU1 might regulate a partner channel (Baughman et
al., 2011; Perocchi et al., 2010).
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Two groups simultaneously identified the uniporter over the next year using the MitoCarta
database. Both groups identified CCDC109A, now called the mitochondrial Ca2+ uniporter
(MCU), as a universally expressed protein that is present in mitochondria, with two TM
domains that oligomerizes to form a larger complex (Baughman et al., 2011; De Stefani et
al., 2011). In order to identify proteins that were co-expressed in proportion to MICU1,
Mootha’s group examined RNA and protein expression profiles (Baughman et al., 2011;
De Stefani et al., 2011). Rizzuto’s group looked in the MitoCarta database for an integral
inner membrane protein that matched the criteria for being the uniporter (De Stefani et al.,
2011; Harrington & Murphy, 2015). Tissue expression profiling by quantitative real time
polymerase chain reaction (PCR) showed ubiquitous presence in all investigated tissues
with expression levels correlating with those of MICU1. (De Stefani et al., 2011). To
confirm their finding of MCU being the channel responsible for mitochondrial Ca2+ uptake,
both groups further showed, in a variety of cell types, that MCU overexpression and
knockdown results in increased mitochondrial Ca2+ and diminished mitochondrial Ca2+
uptake, respectively (De Stefani et al., 2011; Harrington & Murphy, 2015; Kovacs-Bogdan
et al., 2014). Therefore, in 2011, the membrane channel MCU was identified after
approximately five decades after the first characterization of mitochondrial Ca2+ uptake.

1.5

Localization and topology of MCU

The outer mitochondrial membrane (OMM) has channels such as the voltage-dependent
anion channel, allowing Ca2+ to enter through the OMM (Harrington & Murphy, 2015).
Localization of MCU to the IMM was confirmed by De Stefani et al., (De Stefani et al.,
2011) using digitonin-permeablized cells. In this experiment, green-fluorescent protein
(GFP) fluorescence was visualized before and after treatment with proteinase K or Trypan
blue, a fluorescence quencher that crosses the OMM, but not the IMM (De Stefani et al.,
2011; Giacomello et al., 2010). Proteinase K had no effect on MCU-GFP fluorescence but
diminished fluorescence of the cytosolic, OMM-anchored N33D1cpV probe, confirming
that MCU is not on the OMM, whereas Trypan blue abrogated MCU-GFP but not
mitochondrial-GFP fluorescence. Baughman et al., (Baughman et al., 2011) also confirmed
the localization of MCU to the IMM by disrupting the OMM by inducing hypotonic
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swelling and treating the resulting mitoplasts with proteinase K (Baughman et al., 2011).
Proteins such as the oxidase assembly 1 that are exposed to the IMS are digested by
proteinase K, whereas cytochrome oxidase II, an integral inner membrane protein, and
MCU are protected, despite being targets for proteinase K (Baughman et al., 2011).
Although it was established that MCU is an IMM protein with two TM domains, initial
reports disagreed about its topology. Based on protease susceptibility data, Kamer et al.,
(Kamer et al., 2014) suggested that MCU is an IMM protein with its N- and C- termini in
the mitochondrial matrix and only a short linker region containing the DIME motif facing
the intermembrane space (IMS). The DIME motif is a short stretch of conserved amino
acids that link MCU’s two TM domains (TM1 and TM2) (Baughman et al., 2011). Two
negatively charged residues, D and E, in this DIME motif are known to be essential for
MCU function, perhaps by providing Ca2+ binding sites (Baughman et al., 2011; De Stefani
et al., 2011; Lee et al., 2015). They also showed that the S259A mutant of MCU (predicted
to face the IMS) is resistant to the inhibitory action of the cell impermeant, Ru360 (Kamer
et al., 2014). On the contrary, De Stefani et al., (De Stefani et al., 2011) examined the
susceptibility of GFP-tagged MCU to fluorescence quenching and reported the opposite
topology, stating that the N- and C- termini and most of the protein are located in the IMS
(De Stefani et al., 2011). Ultimately, the development and use of ascorbate peroxidase,
which functions as an EM tag, indicated that the N- and C- termini are located in the
mitochondrial matrix (Martell et al., 2012).
Raffaello et al., (Raffaello et al., 2013) performed a molecular dynamics simulation to
predict the channel’s quaternary structure. They developed a comparative model of the pore
domain of MCU and a four-fold symmetry was imposed to the oligomer construction, as
suggested by most of the available crystallographic data of other channel forming proteins.
The three-dimensional averaged structure obtained from the molecular dynamics
simulation of a membrane-embedded MCU model revealed the presence of a narrow
selectivity filter constituted by conserved acidic residues (E257, D260, D261, E263 and
E264) (Raffaello et al., 2013). Subsequently, they looked for experimental confirmation of
the proposed oligomeric structure and found interactions in situ of MCU monomers in a
higher order complex (Raffaello et al., 2013). In vitro translated MCU was separated on a
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native gel, and bands at the expected molecular weight (MW) of the monomer (40 kDa) as
well as at 170 kDa (reactive with a 6×-His antibody), which is compatible with a tetramer,
were identified (Raffaello et al., 2013). These data supported the tetrameric model of MCU
assembly. Kamer et al., (Kamer et al., 2014) also noted that MCU appears to oligomerize
within the IMM as part of a larger MW complex. Baughman et al., (Baughman et al., 2011)
proposed the idea that the DIME motif appears to be critical for Ca2+ transport. They
speculated this from the observation that mutations in this stretch of amino acids (E257A,
S259A, D261A and E264A) and in the C-terminus conferred a marked resistance to both
Ca2+ uptake and the inhibitory effect of Ru360, strongly suggesting that this is the poreforming unit of the uniporter (Baughman et al., 2011). However, despite the speculations
and studies that have been done on the localization and topology of MCU, the precise
structure of MCU is still largely unstudied.

1.6

MCU function in mitochondrial Ca2+ uptake

The mechanism by which Ca2+ is imported across the OMM into the IMS is through the
voltage-dependent anion channel, a large, high-conductance channel and the most abundant
protein of the OMM (Rizzuto et al., 2009). Under resting cytosolic Ca2+ levels, MCU is
inactive; however, upon agonist stimulation leading to increased cytosolic Ca2+ levels and
accumulation of Ca2+ in the IMS, it is the role of MCU as a highly selective Ca2+ channel
to mediate Ca2+ uptake into the mitochondrial matrix (Rizzuto et al., 2009). Ca2+ from the
IMS crosses the IMM through MCU by a negative potential driving force. ATP synthesis
in the mitochondria establishes a large electrical membrane potential of ~-180 mV across
the IMM due to proton efflux (Marchi & Pinton, 2014; Patron et al., 2013) that is an
attractive force for cations (Carafoli, 2003; Raffaello et al., 2012). MCU-overexpressing
cells show a drastic increase in the mitochondrial [Ca2+] rise evoked by histamine compared
to control cells and accordingly, there is a significant reduction in cytosolic [Ca2+], due to
increased Ca2+ uptake by the mitochondria (De Stefani et al., 2011). Additionally, MCUoverexpressing cells show a faster rate of Ca2+ uptake and reach a higher mitochondrial
[Ca2+] plateau level (De Stefani et al., 2011). MCU-expressing cells are more efficiently
killed after treatment with C2-ceramide or hydrogen peroxide, thus confirming the notion
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that mitochondrial Ca2+ loading is correlated with apoptotic signaling (Hajnoczky et al.,
2000a; Pinton et al., 2001).
To obtain evidence of cation permeation across the pore-forming domain, De Stefani et al.,
(De Stefani et al., 2011) mutated into glutamines two negatively charged residues of the
conserved region (D260Q, E263Q) and assessed the electrophysiological properties of the
mutant protein (MCUD260Q,E263Q) produced in vitro. The mutant protein fails to give rise to
Ca2+-permeable channel activity in bilayer experiments (De Stefani et al., 2011) and when
the mutant is overexpressed in HeLa cells, a marked reduction in histamine-induced
mitochondrial [Ca2+] increases is observed compared to MCU-overexpressing and control
cells. Hence, MCUD260Q,E263Q acts as a dominant-negative mutant, likely by inhibiting MCU
channel activity within an oligomer or competing for binding sites or essential regulators
(De Stefani et al., 2011).
Overall, it is critical for MCU to tightly control mitochondrial Ca2+ uptake, as vital
processes are regulated by matrix Ca2+ including apoptosis and energy production.

1.7

Protein regulators of MCU

1.7.1

MCUb

Following the identification of MCU, several associated regulators of MCU and a
dominant-negative paralog of MCU were identified, indicating that MCU exists as a
multiprotein complex with these regulators modulating its activity (Harrington & Murphy,
2015). Although the exact stoichiometry, precise role and mode of interaction with
regulators are still largely unknown and under investigation, it is clear that MCU forms an
ion channel as a heteromeric protein complex. This high level of regulation is consistent
with the important role that mitochondrial Ca2+ and MCU play in cell physiology
(Plovanich et al., 2013).
Genomic analysis reveals a gene which translates into a 33 kDa protein known as MCUb,
sharing ~50% similarity to MCU (De Stefani et al., 2015). MCUb possesses two coiled-
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coil (CC) domains and two TM domains separated by a short loop that slightly differs from
MCU (De Stefani et al., 2015). MCU and MCUb also appear to form hetero-oligomers, as
in situ interaction of MCU and MCUb is observed and fluorescence resonance energy
transfer reveals MCUb self-oligomerization (Raffaello et al., 2013). Additionally, MCUb
has a crucial amino acid substitution in the DIME motif at the loop region (E256V) that
could have an important impact on channeling properties by removing one critical negative
charge (Raffaello et al., 2013).
When MCU and MCUb are co-expressed, MCU activity is significantly reduced to ~13%
compared to MCU-only (Raffaello et al., 2013). Therefore, MCUb subunits greatly impair
Ca2+ permeation when incorporated into the MCU complex, acting in a dominant-negative
manner (Raffaello et al., 2013). In intact cells, MCUb-silencing causes a significant
increase in the histamine-induced mitochondrial [Ca2+] peak, and both MCUb silencing and
overexpression do not alter mitochondrial tetramethylrhodamine methyl ester (TMRM)
loading (Raffaello et al., 2013), which is a cell-permeant, fluorescent dye sensitive to
mitochondrial membrane potential.
In permeabilized cells in which mitochondrial Ca2+ accumulation is initiated, MCUb
silencing increases the uptake rate, whereas MCU silencing significantly reduces it
(Raffaello et al., 2013). In the latter case, MCUb silencing does not rescue Ca2+ uptake
(Raffaello et al., 2013). An analysis of mouse tissues revealed a low level of MCUb
expression that did not correlate with MCU expression. Therefore, based on the mRNA
data, the MCU/MCUb ratio appears to vastly differ in various tissues, which may provide
a mechanism for modulating the efficiency of mitochondrial Ca2+ uptake (Raffaello et al.,
2013).
Overall, MCUb is an endogenous dominant-negative subunit of the MCU complex that
inhibits Ca2+ uptake activity. Furthermore, the MCU/MCUb variations among different
tissues is consistent with a demonstration that the overall activity of the MCU complex is
also highly variable among tissues (Fieni et al., 2012).
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1.7.2

MICU1 and MICU2

Early studies showed that MICU1 was required for mitochondrial Ca2+ uptake, as its
knockdown using RNA interference largely reduced it (Perocchi et al., 2010). In fact, the
high resolution structure for MICU1, a 50 kDa protein consisting of four domains including
two Ca2+-binding EF hands, has been solved (Fig. 1.1).
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Figure 1.1. Ribbon structure of MICU1 and its domains. The structure of MICU1
was obtained from the protein data bank (4NSD) and rendered in PyMol. MICU1
consists of four different domains. Shown are ID1 in blue (residues 107-218), EF1 in
red (219-315), ID2 in yellow (316-373) and EF2 in green (374-444). Ca2+ (cyan
spheres) binding to EF1 and EF2 is also shown.
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MICU2 was discovered in 2014 and is a 45 kDa paralog of MICU1 with ~27% sequence
identity (Harrington & Murphy, 2015). MICU2 was first described as a protein whose
silencing results in reduced mitochondrial Ca2+ clearance in response to large (~50 μM)
extra-mitochondrial Ca2+ pulses (Plovanich et al., 2013). However, there are conflicting
perspectives on the precise role that MICU1 and MICU2 have on MCU activity. Mootha’s
group suggested that both MICU1 and MICU2 are negative regulators of the pore (Kamer
& Mootha, 2014). Rizzuto’s group proposed that MICU2 is an inhibitor and MICU1 is an
activator of channel opening (Patron et al., 2014).
Recently, Matesanz-Isabel’s group shed some light on this discrepancy by showing that at
low cytosolic [Ca2+] from ~100 nM to 4.5 μM, there is a large increase in mitochondrial
Ca2+ uptake in MICU2-silenced cells, whereas above these levels, at ~7 and 10 μM
cytosolic [Ca2+], the rate of mitochondrial Ca2+ uptake is not significantly modified by
MICU2-silencing (Matesanz-Isabel et al., 2016). In fact, the effect of MICU2 decreases
progressively as cytosolic [Ca2+] is increased. These results indicate that MICU2 acts as an
inhibitor of MCU, but only at low cytosolic [Ca2+] and that the regulatory effects of MICU2
disappear as the cytosolic [Ca2+] is increased (Matesanz-Isabel et al., 2016).
MICU1 seems to cooperate with MICU2 to keep MCU closed and set the threshold of MCU
activation at low cytosolic [Ca2+] (Matesanz-Isabel et al., 2016). MICU1 behaves as an
activator of MCU at cytosolic [Ca2+] above ~2.5 μM, whereas removal of MICU2 produces
no effects at cytosolic [Ca2+] of ~7 μM and above. Therefore, MICU2 is a genuine inhibitor
of MCU, though only at low cytosolic [Ca2+], and MICU1 is inhibitory at low cytosolic
[Ca2+] and acts as an MCU activator at high cytosolic [Ca2+] (Matesanz-Isabel et al., 2016).
Although there have been speculations, the location of MICU1 and MICU2 are still
unknown. Mallilankaraman et al., (Mallilankaraman et al., 2012) utilized a pre-pulse
protocol to load the mitochondrial matrix with Ca2+ to test whether MICU1 sensed Ca2+ in
the matrix or the IMS, and concluded that MICU1 senses Ca2+ in the mitochondrial matrix.
On the other hand, using protease sensitivity assays in isolated mitochondria or mitoplasts,
several groups have concluded that MICU1 is localized in the IMS (Csordas et al., 2013;
Kamer & Mootha, 2014; Patron et al., 2014; Wang et al., 2014). However, another group
image-tagged mitochondrial proteins in plasma membrane-permeabilized cells in response
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to outer and inner membrane permeabilization and concluded that MICU1 behaves as if it
is localized in the matrix (Hoffman et al., 2013). Thus, despite the extensive studies done
on MICU1 and MICU2, many unanswered questions remain on their localization and even
function, limiting our full understanding of MCU regulation.
1.7.3

Essential MCU regulator (EMRE)

EMRE, discovered in 2013, is a broadly expressed 10 kDa single-pass IMM regulator with
a highly conserved C-terminus rich in aspartate residues that appears to be essential to
MCU function (De Stefani et al., 2015; Harrington & Murphy, 2015). In both isolated
mouse cells and organelles, EMRE silencing renders MCU completely ineffective and
cannot be rescued by MCU overexpression (Sancak et al., 2013). So far, in vivo
reconstitution experiments using Dictyostelium discoideum MCU have shown that
although MICU1 and MICU2 are important MCU regulators, they are not essential for
MCU function, unlike EMRE (Kovacs-Bogdan et al., 2014). Therefore, EMRE represents
the first identified regulator essential for uniporter activity (Harrington & Murphy, 2015).
Interestingly, MCU silencing results in decreased EMRE protein levels even though normal
levels of EMRE mRNA are present, suggesting that EMRE loss is due to protein
destabilization caused by the loss of MCU (Harrington & Murphy, 2015).
Consistent with EMRE being a core component of the MCU complex, EMRE loss results
in reduced size of the complex on a native gel (Sancak et al., 2013). Furthermore, coimmunoprecipitation experiments showed that the loss of EMRE specifically disrupts the
association of MCU with MICU1 and MICU2. However, interactions between MCUb,
MICU1 and MICU2 all appear to be dispensable for MCU-EMRE interactions since EMRE
remains associated with immunoprecipitated MCU-FLAG in cells lacking MCUb or
MICU1 (Sancak et al., 2013).
Despite these findings, the reasons why MCU requires association with EMRE for in vivo
Ca2+ conductance needs further investigation. Additional experimental work is also
required to understand precisely how the activity of MCU is regulated by EMRE.
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1.7.4

MCU regulator 1 (MCUR1)

MCUR1 is a 40 kDa protein with two TM domains and one CC region, with its N- and Ctermini facing the IMS (Harrington & Murphy, 2015). When expressed in Drosophila
S2R+ cells, MCUR1 markedly reduces the Ca2+ threshold for the mPTP opening
(Chaudhuri et al., 2016). On the contrary, genetic inhibition of MCUR1 makes mammalian
cells resistant to Ca2+ overload and protects them from consequent cell death (Chaudhuri et
al., 2016). Although the Ca2+ uptake results vary, it was concluded that MCUR1 is not
essential for mitochondrial Ca2+ transport in all species, as Drosophila cells display intact
Ca2+ uptake despite an absence of an MCUR1 homolog (Mallilankaraman et al., 2015).
Furthermore, Ca2+ uptake does not change after MCUR1 overexpression in S2R+ cells or
after acute/moderate inhibition in mammalian cells, despite altered Ca2+ sensitivity of the
mPTP (Mallilankaraman et al., 2015). Initially, MCUR1 was identified as an essential
subunit of MCU (Mallilankaraman et al., 2015), while a second report suggests that
MCUR1 assists in complex assembly (Paupe et al., 2015).
Although our understanding of MCU and its modulation by regulators has been evolving
quickly over the past several years (Fig. 1.2), there remains many unanswered questions on
precisely how the interactions with these regulators change to mediate the ON/OFF activity
of MCU.
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Figure 1.2. Schematic representation of the MCU complex. This schematic
representation is adapted from (De Stefani et al., 2015), with both low and high
cytosolic [Ca2+] conditions indicated (Matesanz-Isabel et al., 2016). Mitochondrial
Ca2+ uptake is controlled by a multiprotein complex composed of MCU and MCUb
(the channel forming subunits) together with EMRE, MICU1, and MICU2 (other
components are omitted for the sake of clarity). In resting conditions (left), Ca2+
signaling is off as MICU1/MICU2 heterodimers act as MCU gatekeepers, due to
inhibitory effects of MICU1 and MICU2 in low [Ca2+], thus preventing vicious Ca2+
cycles. Once Ca2+ signaling is activated by high [Ca2+], the increase in extramitochondrial [Ca2+] (right) induces a conformational change, with MICU1
becoming activated despite MICU2 inhibitory activity. This results in MICU1mediated enhancement of MCU channeling activity, taking up Ca2+ into the
mitochondrial matrix. MICU1 and MICU2 localization in the IMS is based off of my
standpoint from previous studies that have been done.
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1.8

MCU downregulation and knockout

Mitochondrial Ca2+ homeostasis participates in the control of the intrinsic pathway of
apoptosis and is influenced by oncogenes, suggesting that it is involved in tumorigenesis
(Clapham, 2007; Giorgi et al., 2012; Pinton et al., 2008; Roderick & Cook, 2008).
The identification of MCU and MICU1 has allowed molecular investigation of this process,
including the regulation of their expression by microRNAs, which are a class of small (1925 nucleotides), non-coding regulatory RNAs that modulate gene expression, causing
target mRNA degradation or suppressing mRNA translation (Filipowicz et al., 2008).
Recently, five cancer-related microRNA families were predicted to target MCU and/or
MICU1; furthermore, miR-25 was shown to cause a marked reduction in the mitochondrial
[Ca2+] rise evoked by histamine (Marchi et al., 2013). Accordingly, overexpression of an
anti-miR-25 increased mitochondrial Ca2+ uptake induced by histamine (Marchi et al.,
2013). Immunoblotting showed a marked reduction in the protein level upon miR-25
overexpression and an increase in anti-miR-25-expressing cells. Marchi et al., (Marchi et
al., 2013) also found that miR-25-expressing HeLa cells were strongly protected from death
induced by C2-ceramide and hydrogen peroxide-induced apoptotic challenges (Marchi et
al., 2013).
Interestingly, it has been shown that prostatic cells possess very high levels of miR-25 and
are strongly sensitized to apoptosis after MCU overexpression (Marchi et al., 2013).
Prostate and colon cancer cell lines both demonstrate high miR-25 levels and low MCU
expression levels (Marchi et al., 2013). Overall, miR-25 is highly expressed in colon and
prostate cancer cells, which reduces their sensitivity to apoptotic agents, highlighting MCU
signaling as a novel target for cancer therapy.
MCU knockout studies have been performed in mice. The Finkel lab created MCU -/- mice
to further elucidate the role of MCU in biologic processes (Harrington & Murphy, 2015;
Pan et al., 2013). Mitochondria from MCU -/- mice, mouse embryo fibroblasts (MEFs), and
isolated adult cardiac myocytes have the inability to rapidly uptake Ca2+ into the
mitochondria (Pan et al., 2013). As expected, wild-type (WT) mitochondria are able to
quickly and efficiently take up Ca2+, unless treated with ruthenium red or Ru360 to inhibit
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MCU, which reduces mitochondrial Ca2+ levels comparable to those observed in the
MCU

-/-

mice (Pan et al., 2013). Interestingly, MCU deletion has no obvious effects on

aerobic respiration in the purified mitochondria from MCU -/- mice (Pan et al., 2013).
Furthermore, there are no detectable differences in aerobic metabolism between MCU -/and WT MEFs using a variety of substrates (Pan et al., 2013), suggesting that basal
metabolism is not markedly altered in the absence of MCU expression. However, in skeletal
muscle, under conditions of maximum work evaluated by an inclined treadmill test and
grip strength, the MCU-/- mice have reduced abilities to generate maximal power (Pan et
al., 2013). Although MCU-/- mice were viable when outbred, they were born in nonMendelian ratio, suggesting that there is some embryonic lethality (Murphy et al., 2014).
Additionally, MCU-/- is embryonically lethal in mice with a C57 background (Murphy et
al., 2014). As expected, MCU-/- mice show a significant reduction in total mitochondrial
matrix Ca2+ (Pan et al., 2013). The presence of mitochondrial Ca2+ in the MCU-/- mice and
the non-embryonic lethality suggests that there are alternative mechanisms for Ca2+ entry
that may compensate in the absence of MCU, such as the Letm1 Ca2+/H+ antiporter (Jiang
et al., 2013).
Interestingly, when exposed to pathologic levels of Ca2+, mitochondria or permeabilized
MEFs from MCU-/- mice exhibit no signs of mPTP opening (Pan et al., 2013). However,
there is no evidence that the MCU-/- MEFs are protected from cell death, since they die as
quickly and in similar numbers to WT MEFs, and the MCU-/- cells show similar levels of
caspase-3 activation and mitochondrial swelling (Pan et al., 2013). It is possible that the
mPTP in the MCU-/- cells is activated in a Ca2+-independent manner, which would be
consistent with suggestions that reactive oxygen species are primary activators of mPTP in
vivo (Lemasters et al., 2009; Zorov et al., 2014).
In conclusion, since the discovery of mitochondrial Ca2+ uptake and MCU, it is clear that
the uniporter exists as a complex with multiple regulatory proteins. However, although a
variety of regulators and a paralog of MCU have been identified, their exact roles and
stoichiometric variance from tissue to tissue are still not fully understood. Studies on MCU
downregulation and on MCU-/- mice have helped us further understand the physiological
significance of MCU as a key player in mitochondrial Ca2+ homeostasis. Nevertheless,
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understanding the mechanisms of MCU function and regulation at the molecular level is
still highly lacking and needed to not only grasp the importance of the uniporter and its
regulators on mitochondrial Ca2+ homeostasis, but more broadly on human health.

1.9

Rationale and hypothesis

Despite the realization that MCU functions as a multifaceted oligomer and the
identification of a suite of proteins involved in the complex formation, an understanding of
the precise atomic and molecular mechanisms of regulation is highly lacking in the field.
Furthermore, while many Ca2+ channel proteins exhibit Ca2+-dependent feedback
mechanisms including IP3Rs (Bezprozvanny et al., 1991; Mak et al., 1998), ryanodine
receptors (Meissner et al., 1986) and Ca2+ release-activated Ca2+ channels (Hoth & Penner,
1993; Zweifach & Lewis, 1995), it is unclear how dibasic cations may play a regulatory
role in the function of MCU. Solving these unknown issues will not only help to gain a
better understanding of mitochondrial Ca2+ regulation via MCU and its regulators, but will
also lay the foundation to the future design of modulators of MCU activity that have a
potential to treat a range of Ca2+-related pathological processes.
I hypothesize that the prevalent mitochondrial matrix cations Ca2+ and Mg2+ regulate the
structure and activity of MCU. Studies on the structural effects of dibasic cation binding to
MCU will increase our understanding of the precise atomic and molecular mechanisms of
MCU function and regulation.
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Chapter 2

Materials and Methods
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2.1

Cloning and mutagenesis of MCU constructs

Full length GFP-tagged MCU cDNA was graciously gifted by Muniswamy Madesh
(Temple University). All primers (Sigma) used in this thesis are compiled in Table 1. With
their respective primers, the sequence of interests, WT MCU construct 5 (MCU105-189) and
MCU construct 6 (MCU72-189), were amplified by PCR using Thermo Phusion DNA
Polymerase and Thermo Scientific 10 mM dNTP mix. PCR amplification of both constructs
involved one cycle of denaturation at 98°C for 30 seconds, followed by 35 cycles of
denaturation at 98°C for 10 seconds, annealing at 56°C for one minute and extension at
72°C for one minute, with a final extension at 72°C for one minute. The PCR products and
pET-28a vectors encoding a 6×-His tag (Novagen) were then both digested with NheI and
XhoI (New England Biolabs) overnight at 37°C, followed by gel purification of the
digested products using a GenepHlow Gel/PCR Kit (GeneAid). The DNA fragments were
ligated in a 20 μL reaction volume with a 3:1 ratio of insert to vector DNA by using T4
DNA ligase (New England Biolabs). Afterwards, 5 μL of each of the ligated products were
then placed into an Eppendorf tube containing 100 μL of DH5α cells for transformation.
The Eppendorf tubes containing the ligated products and DH5α cells were heat shocked at
42°C for 45 seconds and placed on ice for two minutes. All of the cells were then added to
900 μL of Luria-Bertani (LB) in a falcon tube and incubated with constant shaking at 37°C
for 90 minutes. The cells were then centrifuged down and resuspended with 150 μL of LB
medium and plated on kanamycin-containing agar plates to be incubated overnight at 37°C.
To ensure the ligated products were in the bacteria, colony PCR was performed with 2×
Taq Frogga Mix along with T7 forward and T7 reverse primers. After setting up 15
Eppendorf tubes with colonies resuspended in autoclaved H2O and running PCR under the
same conditions as above, agarose gel electrophoresis was performed followed by staining
with ethidium bromide to identify colonies harboring the expected insert size. Positive
colonies were grown overnight in 5 mL LB + kanamycin and incubated overnight at 37°C.
The final kanamycin concentrations in all cloning, expression and purification procedures
were 60 μg mL-1. Plasmid mini-preparation was then performed to isolate the plasmid DNA
using a Presto Mini Plasmid Kit (GeneAid), following the protocol as described by the
manufacturer. DNA sequencing was then performed at the DNA Sequencing Facility of the
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Robarts Research Institute (London, Ontario) to confirm the insert sequences, with
sequencing reactions prepared according to their guidelines using T7 forward or reverse
primers.
The MCU72-189 I141M/L146M, MCU72-189 D131R and MCU72-189 D147R mutations were
each generated by QuikChange site-directed mutagenesis (Stratagene). Mutagenic primers
(Table 1) were used to amplify the entire pET-28a vectors that contained the MCU72-189
WT template inserts. The PCR for mutagenesis involved one cycle of denaturation at 98°C
for 30 seconds, followed by 35 cycles of denaturation at 98°C for 10 seconds, annealing at
56°C for 30 seconds and extension at 72°C for three minutes, with a final extension at 72°C
for five minutes. DpnI was used to digest the methylated template DNA for two hours at
37°C. The PCR amplification products were then transformed into DH5α cells. Plasmids
from the resultant colonies were propagated and purified by plasmid mini-preparation as
described above. Mutations were confirmed by DNA sequencing, as described above.
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Table 1
Primers used in this thesis. Underlined sequences indicate NheI
restriction sites (GCTAGC) and XhoI restriction sites (CTCGAG). All primers are shown
in the 5’ to 3’ direction.
Primer

Sequence
ACACTCAAGGCTAGCTCTGACTCGTTGGTGTATTTTTACG

MCU5 S105 Sense

MCU6 S72 Sense

GCAGCACTGTTGCTAGCTCTGATGATGTTACAGTGG

MCU6 T189
Antisense

GTTTAACTGGTGCTGCTCCTCGAGCTATGTGGTGTATAGTTG

MCU6

GCTGCTTCAACAGGAATGGACCTCCTCCTCATGGATGACTTTAAGCTG

I141M/L146M
Antisense
MCU6

CAGCTTAAAGTCATCCATGAGGAGGAGGTCCATTCCTGTTGAAGCAGC

I141M/L146M
Antisense
MCU6 D131R

GCTATCTATTCACCACGTGGTGTTCGCGTTGCTGC

Sense

MCU6 D131R

GCAGCAACGCGAACACCACGTGGTGAATAGATAGC

Antisense

MCU6 D147R

GACCTCCTCCTCCTTCGTGACTTTAAGCTGGTC

Sense

MCU6 D147R
Antisense

GACCAGCTTAAAGTCACGAAGGAGGAGGAGGTC
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2.2

Expression and purification of MCU constructs

WT MCU105-189 and WT, D131R, or D147R MCU72-189 pET-28a constructs were all
transformed in BL21 (DE3) codon + Escherichia coli. First, 1.25 μL of DNA for each
construct were added into 100 μL of BL21 (DE3) codon + Escherichia coli and incubated
on ice for 45 minutes. The cells were then heat shocked at 42°C for 45 seconds, and placed
on ice for two minutes. The cells were then added to 900 μL of LB in a falcon tube and
incubated for 60 minutes at 37°C and ~200 rotations per minute (rpm). Next, 100 μL of the
cells were then spread onto kanamycin-containing agar plates and incubated overnight at
37°C. The next day, a single colony was inoculated in 25 mL of LB medium containing
kanamycin and grown overnight at 37°C. The next day, this starter culture was equally
divided into two larger flasks containing 500 mL of LB each, supplemented with
kanamycin. The cells were grown at 37°C to an OD600nm of ~0.6-0.8, and 200 μM of
isopropyl β-D-1-thiogalactopyranoside was added to induce expression over a 16 hour
period at 22°C. Cells were harvested using a centrifuge (Beckman Model J2-21M) at
9,300× g for 25 minutes at 8°C. Harvested cells were then stored at -20°C in conical tubes
until purification.
The I141M/L146M MCU72-189 construct was used for seleno-methionine (Se-Met)
incorporation. Transformation and starter cultures were prepared as described above. For
Se-Met incorporation, cells were large scale cultured in M9 medium supplemented with
kanamycin. First, 1 L of M9 salt solution was prepared by adding 41.4 mM anhydrous
Na2HPO4, 22.0 mM KH2PO4 and 8.6 mM NaCl filled up to 1 L of nanowater with a pH of
7.4. The large flask with the M9 salt solution was then autoclaved. Once the flasks were
cooled down, the following additives were then filtered through a 0.22 μm syringe into the
M9 salt solution: 11.1 mM D-glucose, 18.7 mM NH4Cl, 0.1 mM thiamine, 4.1 μM biotin,
0.1 mM CaCl2 and 0.1 mM MgSO4.
Starter culture cells were centrifuged (Thermo Scientific Sorvall ST 16R centrifuge) at
2,400× g for 15 minutes at 8°C and the LB medium was decanted. The cell pellet was
resuspended in ~10-15 mL of the M9 medium supplemented with kanamycin and
transferred into the 1 L M9 medium for growth. Cells were incubated with constant shaking
at ~180 rpm at 37°C to an OD600nm of ~0.6-0.8. Subsequently, the following amino acids
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were added to inhibit methionine biosynthesis: 0.6 mM phenylalanine, 0.7 mM lysine, 0.8
mM threonine, 0.4 mM leucine, 0.4 mM isoleucine and 0.4 mM valine. This was followed
by the addition of 0.3 mM Se-Met for incorporation. After 15 minutes of incubation at 37°C
and ~180 rpm, the medium and cells were split evenly into two 2 L flasks (i.e. 500 mL in
each) and 200 μM isopropyl β-D-1-thiogalactopyranoside was added to induce expression
over a 16 hour period at 22°C. Cells were harvested and stored for purification as described
above.
For purification, frozen MCU72-189 cell pellets were lysed and denatured with 6 M guanidine
hydrochloride (GnHCl), 20 mM Tris (pH 8.8) and 5 mM 2-Mercaptoethanol, whereas
MCU105-189 was denatured with 6 M GnHCl and 20 mM Tris (pH 8). Cell pellets were well
homogenized by mechanical agitation using a transfer pipette. Cell suspensions were
subsequently placed in a rotating hybridization oven for 90 minutes at ambient temperature.
Lysates were clarified by centrifugation (Thermo Scientific Sorvall ST 16R centrifuge) at
10,000× g for 30 minutes at 8°C. Approximately 1.5 mL of a ~30% (v/v) slurry of
Ni-nitriloacetic acid (Ni-NTA) agarose resin (Qiagen) was added to the clarified
supernatant (~40 mL) and incubated for 90 minutes on the rotating hybridization oven. The
Ni-NTA resin was subsequently captured on a column and the flow-through was disposed.
The resin was washed with 3× 10 mL volumes of wash buffer containing 6 M urea, 20 mM
Tris (pH 8.8) and 5 mM 2-Mercaptoethanol for MCU72-189 constructs, whereas for
MCU105-189 constructs, the column was washed with 3× 10 mL volumes of wash buffer
containing 6 M urea and 20 mM Tris (pH 8). The 6×-His tagged MCU72-189 bound to the
resin was eluted with seven fractions of 2 mL elution buffer containing 6 M urea, 300 mM
imidazole, 20 mM Tris (pH 8.8) and 5 mM 2-Mercaptoethanol, whereas the 6×-His tagged
MCU105-189 was eluted with 6 M urea, 300 mM imidazole and 20 mM Tris (pH 8). Each of
the seven fractions were collected 2 mL at a time with an incubation time of two minutes.
Afterwards, 17.5 μL aliquots of the elution fractions prepared in Laemmli sample loading
dye were individually assessed by denaturing sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) in 15% (v/v) acrylamide gels, which were run at 195 volts
(V) for 55 minutes.
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The gels were then Coomassie blue stained for 20 minutes, followed by destaining for 20
minutes. The destained gels were visualized under a white light transilluminator (VWR
Scientific) to check the presence of the protein bands at its corresponding MW at high
purity, as shown in Figure 2.1A.
The MCU72-189 eluted fractions (i.e. ~14 mL) were refolded by dialysis using a 3,500
molecular weight cut off (MWCO) membrane (BioDesignDialysis Tubing) overnight in
1 L of buffer containing 20 mM Tris (pH 8.8), 150 mM NaCl and 1 mM dithiothreitol
(DTT), whereas the eluted MCU105-189 fractions were dialyzed overnight in refolding buffer
containing 20 mM Tris (pH 8) and 150 mM NaCl. The 6×-His tags were subsequently
cleaved by adding ~1 U mg-1 thrombin (BioPharm) to the dialysis bags and dialyzed in
buffer containing 20 mM 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
(pH 8.5), 150 mM NaCl and 1 mM DTT for ~24 hours. MCU105-189 6×-His tags were
cleaved in dialysis buffer containing 20 mM Tris (pH 7.5) and 150 mM NaCl for ~24 hours.
Thrombin cleavage efficiency was checked by SDS-PAGE as described above. The gels
were then stained in Coomassie blue stain and destained for 20 minutes each and visualized
under white light using the transilluminator (VMR Scientific) (Figure 2.1B).
After thrombin digestion, proteins were further purified by 5 mL HiTrap Q (GE Healthcare)
anion exchange chromatography (GE Healthcare). All proteins were concentrated to
~1.5 mL using an Amicon Ultra-15 10 K (Millipore) and were negatively charged at the
loading buffer pH to bind to the positively charged column resin. The pI of MCU72-189 and
MCU105-189 with bound 6×-His tag are 7.30 and 6.79 respectively, whereas the pI of the
MCU72-189 D131R and D147R mutants with bound 6×-His tag are both 8.27. Without bound
6×-His tag, the pI of MCU72-189 and MCU105-189 are 6.30 and 5.38 respectively, whereas the
pI of the MCU72-189 D131R and D147R mutants are both 7.47. The loading buffer for the
MCU72-189 construct was 20 mM HEPES (pH 8.5) and 1 mM DTT, whereas the loading
buffer for the MCU105-189 constructs was 20 mM Tris (pH 7.5). To elute the proteins of
interest, a high salt buffer containing 20 mM HEPES (pH 8.5), 1 M NaCl and 1 mM DTT
for MCU72-189 constructs and 20 mM Tris (pH 7.5) and 1 M NaCl for MCU105-189 constructs
was used. All buffers were filtered and degassed. By increasing the salt concentration using
a linear salt gradient from 0-60%, the molecules with the weakest ionic interactions were
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eluted from the column first, while those with stronger ionic interactions require a higher
salt concentration and elute later in the gradient. All fractions were eluted at a flow rate of
1 mL min-1 and collected in Eppendorf tubes in 1.5 mL fractions. All fractions were run on
SDS-PAGE as described above to assess the purity of the fractions and confirm the identity
of the proteins of interest (Figure 2.1C).
Once proteins were confirmed to be present and high in purity, the appropriate fractions
were collected together and placed in 3,500 MWCO dialysis tubing (BioDesignDialysis
Tubing). All proteins were dialyzed overnight in a final buffer containing 20 mM HEPES
(pH 7.5), 150 mM KCl and 2 mM DTT which were used in all experiments unless otherwise
stated. Once dialyzed, proteins were concentrated using an Amicon Ultra-15 10 K
(Millipore) to its appropriate concentration and stored at 4°C.
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Figure 2.1. SDS-PAGE gels of MCU72-189. (A) SDS-PAGE gel of eluted MCU72-189
protein with 6×-His tag purification fractions. MCU72-189 with 6×-His tag bands are
seen at its approximate corresponding MW of 15.8 kDa as calculated by Protein
Calculator v3.4. Darker bands indicate high amounts of protein, whereas lighter
bands above the corresponding MW indicate contaminants or oligomers. Protein
eluted from the Ni-NTA beads are estimated to have a purity >90%, as visualized by
the intensity of the protein bands and a small presence of contaminant or
oligomerized MCU72-189 bands (arrows). (B) SDS-PAGE gel assessment of MCU72-189
thrombin cutting efficiency of 6×-His tag. Sufficient thrombin cleaving of 6×-His tag
is shown, with a band at approximately 15.8 kDa pre-thrombin (1), and a band at
approximately 13.9 kDa post-thrombin (2), which is the expected MW of MCU72-189
without the 6×-His tag, as calculated by Protein Calculator v3.4. Less intense bands
above the corresponding MW indicate contaminants or oligomers of MCU72-189
(arrows). (C) SDS-PAGE gel of MCU72-189 anion exchange chromatography elution
fractions. The selected Eppendorf tube fractions show protein bands with strong
intensity at approximately 13.9 kDa, which is the MW of MCU72-189 without the
6×-His tag, as calculated by Protein Calculator v3.4. Less intense bands above the
corresponding MW indicate contaminants or oligomers (arrows). However, the
protein is highly pure (>90%), allowing for further experiments. Note that selected
fractions in between 3-14 not shown on the gel were also used for experiments.
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2.3

Mass spectrometry of MCU72-189

The final dialyzed MCU72-189 was diluted to 0.5 mg mL-1 with 25 mM ammonium
bicarbonate with a total volume of 100 μL. A 7,000 MWCO Zeba Spin Desalting Column
(Thermo Scientific) was centrifuged at 1,500× g for one minute at 8°C (Thermo Scientific
Sorvall Micro 21R Centrifuge). The column was then washed with 300 μL of ammonium
bicarbonate three times for one minute each. After washing, 85 μL of the protein sample
was added to the column and placed in a sterile Eppendorf tube. The sample was then eluted
(Thermo Scientific Sorvall Micro 21R Centrifuge) at 1,500× g for two minutes at 8°C. The
prepared sample was then sent to the Biological Mass Spectrometry Laboratory (Western
University, London, ON) for electrospray ionization mass spectrometry to confirm the
identity of the protein obtained after the final purification step (Figure 2.2). This was
performed by the technician (Paula Pittock) on a Q-Tof Micro Mass spectrometer (Waters)
equipped with a Z-spray source and run in positive ion mode. The MS survey data range
was 600-1800 with a cone voltage of 25 V and a source temperature of 80°C. Calibration
was performed with myoglobin with a mass error of 0.5 Da and the acquisition software
was MassLynx 4.1 (Waters).
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Figure 2.2. Mass spectrometry data of MCU72-189. X-axis represents the MW in Da
and the Y-axis represents the relative intensity (%). The MW weight shown at
13863.88 Da essentially matches the theoretical MW of MCU72-189 of 13863.73 Da,
confirming the presence of the protein to carry on with experiments knowing the
protein of interest is present. The other peaks may represent contaminants or protein
fragments.
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2.4

Crystallization of MCU72-189 constructs

All crystals were grown at 18°C using the hanging-drop vapor diffusion method with 24well crystallization plates (Nextal). Purified protein in 20 mM HEPES (pH 7.5), 150 mM
KCl and 2 mM DTT were concentrated to ~4.5 mg mL-1 using Amicon Ultra-15 10 K.
Crystallization of MCU72-189 was initially screened by mixing 1 μL of protein (2.84 mg
mL-1) with 1 μL of precipitant using Heavy and Light Twin Pack, Wiz I and II and Pact
Premier kits, equilibrated against 500 μL of 1.5 M (NH4)2SO4. Further optimization was
performed with the conditions that gave crystals, testing varying protein to precipitant ratios
ranging from 1:1 to 3:1, equilibrated against varying concentrations of (NH4)2SO4, ranging
from 1.1 M to 1.7 M. For this further optimization process, there were 96 different
conditions performed, followed by an additional 72 conditions for further optimization.
Ultimately, apo native MCU72-189 was crystallized by mixing 1 μL of protein with 1 μL of
precipitant (0.2 M LiSO4, 0.1 M imidazole, 10% polyethylene glycol (PEG) 3000, pH
8.0) and equilibrated against 500 μL of 1.5 M (NH4)2SO4. Native MCU72-189 was also
crystallized in a similar manner using 0.32 M MgCl2, 0.1 M Tris (pH 8.5), 24% PEG 400
equilibrated against 500 μL of 1.6 M (NH4)2SO4 or 0.2 M calcium acetate, 0.1 M imidazole,
10% PEG 8000, pH 8.0 equilibrated against 500 μL of 1.3 M (NH4)2SO4. The Se-Met
derivatized I141M/L146M MCU72-189 mutant was crystallized under the same conditions
as the native in the presence of MgCl2. Crystals were grown for three days to an average
size of 300 × 50 × 50 μm3, and the subsequent crystal mounting, diffraction, data collection,
phasing and refinement were graciously performed by the Junop laboratory. Singlewavelength anomalous diffraction for Se-Met derivatized I141M/L146M and native
datasets for MCU72-189 were collected at a wavelength of 0.979 Å under cryogenic
conditions (100 K) at the Canadian Light Source CMCF08ID beamline. Data were
processed using iMosflm (Battye et al., 2011). For Se-Met derivatized I141M/L146M
MCU72-189, Phenix was used to locate the Se sites, phasing, density modification and model
building (Adams et al., 2010). For all native datasets, the structures were determined by
molecular replacement using the I141M/L146M structure as a search model in Phenix
(Adams et al., 2010). Refinement of mutant Se-Met and native MCU structures were
carried out utilizing multiple interactions of Coot and Phenix-Refine until R and Rfree values
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converged and geometry statistics reached suitable ranges (Adams et al., 2010; Emsley et
al., 2010). The final model for Se-Met derivatized I141M/L146M MCU72-189 omitted
several residues due to disorder, including: residues 72 and 168-189. The same residues
were also missing in the native MCU72-189 structures. All crystal structures shown in the
figures were rendered in PyMOL.

2.5

Far-UV circular dichroism (CD) spectroscopy

Protein secondary structure was assessed by far-UV CD spectroscopy, which measures the
differences in the absorption of left-handed circularly polarised light and right-handed
circularly polarised light of the protein. CD spectra were acquired on a Jasco J-810
spectropolarimeter equipped with a Peltier temperature control system (Biomolecular
Interactions and Conformations Facility, Western University, London, ON) using a quartz
cell with a path length of 0.1 cm. Each spectrum was taken at 4°C with an average of three
scans acquired between 200 and 250 nm (unless otherwise stated) at a speed of 20 nm
min-1, data pitch of 1 nm and a response time of 8 seconds. CD spectra were corrected for
buffer contributions and values were converted to mean residue ellipticity (MRE). All CD
experiments were done using a protein concentration of 0.5 mg mL-1 unless stated
otherwise.
Thermal melts were acquired by monitoring the change in CD ellipticity at 222 nm while
heating the samples from 5-90°C at a rate of 1°C min-1. The thermal melt data pitch was
1°C using a response time of 8 seconds. Data points from the melting curves were
normalized from 0 to 1 and the apparent temperatures where the fractional change in
ellipticity was approximately 0.5 (Tm) were extracted as an indicator of stability. Thermal
melts were acquired using a protein concentration of 0.5 mg mL-1 unless stated otherwise.
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2.6

Size exclusion chromatography with in-line multi-angle light scattering (SECMALS)

SEC was performed on a Superdex 200 Increase 10/300 GL column linked to an AKTA
pure fast protein liquid chromatography system (GE Healthcare) housed at 4°C. MALS
measurements were performed in-line with the SEC using a 16-angle Dawn Heleos II lightscattering instrument equipped with a 662-nm laser (Wyatt Technologies). Protein
concentrations through the eluted peaks were measured with an in-line Optilab T-rEX
differential refractometer (Wyatt Technologies) with a 658-nm laser and a refractive index
increment of dn·dc−1 = 0.185 mL·g−1. For this experiment, proteins were dialyzed in a final
buffer containing 20 mM HEPES (pH 7.5), 150 mM KCl and 0.5 mM DTT. The running
buffer for the Ca2+-free experiment was 20 mM HEPES (pH 7.5), 150 mM KCl and 0.5
mM DTT, whereas the running buffer for the Ca2+-loaded experiments was 20 mM HEPES
(pH 7.5), 150 mM KCl, 40 mM CaCl2 and 0.5 mM DTT. All protein concentrations used
for this experiment were 2.0 mg mL-1. Three repetitions for both Ca2+-free and Ca2+-loaded
experiments for each protein were performed. Samples were eluted at a flow rate of 0.35
mL min-1 and molecular weights were calculated using the ASTRA software v6.1.5.22
(Wyatt Technologies).

2.7

Analytical ultracentrifugation (AUC) sedimentation equilibrium

Sedimentation equilibrium studies were carried out using a Beckman Optima XL-A
Analytical Ultracentrifuge (Biomolecular Interactions and Conformations Facility,
Western University) at 25°C. Final dialyzed MCU72-189 was concentrated to a minimum of
1.2 mg mL-1. AUC was performed with three concentrations (1.2 mg mL-1, 0.8 mg mL-1,
0.4 mg mL-1) in both Ca2+-free and Ca2+-loaded states. An An60Ti rotor and six-channel
cells with Epon-charcoal centerpieces were used. For loading, 125 μL of the sample buffers
and 110 μL of samples with different protein concentrations were pipetted into the channel
centerpieces. Absorbance measurements at 280 nm were collected in 0.002 cm radial steps
and averaged over 10 readings. The densities of solvents were calculated from published
tables (Rissato et al., 2005; Yurdakok-Dikmen et al., 2016).
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Data were analyzed using the global single ideal species model defined as:
c

c exp

M

1 ⊽ρ r

r

where cr is the concentration at radius r, co is the concentration at reference radius ro, ω is
the angular velocity of the rotor, Mobs is the molecular weight of the protein, ⊽ is the partial
specific volume of MCU72-189, calculated from its amino acid composition as 0.738 mL
g-1, ρ is the density of the solvent, R is the ideal gas constant, T is the temperature in Kelvins,
and Io is the baseline offset. Data were also analyzed according to a monomer-dimer
equilibrium model defined as:
c

c exp

M

1 ⊽ρ r

r

nM

1 ⊽ρ r

r

Where KA is the equilibrium association constant, Mm is the theoretical mass of the
monomer, and other terms are defined as above. All data fitting was done using Graphpad
Prism 5.

2.8

Ca2+ and Mg2+ binding estimates by intrinsic fluorescence

Changes in intrinsic fluorescence of MCU72-189 as a function of CaCl2 or MgCl2
concentrations were taken as an estimate of binding affinity. Experiments were performed
using a Cary Eclipse Fluorescence Spectrophotometer with an excitation wavelength (ex)
of 280 nm and excitation and emission slit widths of 5 and 10 nm, respectively. The
photomultiplier was set at a voltage of 650 V. Emission spectra were acquired between 290
to 350 nm on 0.5 mg mL-1 samples placed in a 1.0 cm path length quartz cuvette and
equilibrated at 25°C. Increasing concentrations of CaCl2 or MgCl2 from 0 mM to 10 mM
were added to the samples to measure the change in relative fluorescence intensity. A
similar molar concentration of free Tyr in solution showed nominal changes in fluorescence
up to 17 mM CaCl2. Binding curves were fit to a one-site binding model taking into account
protein concentration by non-linear regression defined as:
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Where P is the protein, Me is the metal, Fbound is the fraction of bound protein, Ffree is the
fraction of free protein, Ptot is the total protein, Yobs is the observed signal, Io is the initial
signal, and Isat is the saturated signal. All data fitting was done using Graphpad Prism 4.

2.9

Chemical denaturation curves

Equilibrium denaturation curves were obtained for MCU72-189 by diluting the concentrated
stock protein to 5 μM in increasing GnHCl concentrations. Samples were equilibrated at
20°C for 90 minutes using a temperature-controlled water bath incubation (Lauda
Brinkmann Ecoline RE 120). Intrinsic fluorescence measurements were done using the
Cary Eclipse Fluorescence Spectrophotometer. An ex of 275 nm and emission wavelength
(em) of 305 nm were used with excitation and emission slit widths set to 5 and 20 nm,
respectively. Fluorescence from samples placed in 1.0 cm path length quartz cuvettes were
averaged over 60 seconds for each point.
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Results
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3.1

MCU contains a conserved β-grasp-like matrix domain

Human MCU is a ~40 kDa protein that is made up of 351 amino acids (NCBI, Q8NE86)
(Fig. 3.1). MCU contains a mitochondrial signal peptide localized in the first 49 N-terminal
residues (Emanuelsson et al., 2000), as well as two predicted TM domains (TM1, residues
234-256; TM2, residues 266-283) near the C-terminal region (Krogh et al., 2001;
Sonnhammer et al., 1998). Additionally, prior to TM1 and after TM2, two putative CC
domains can be identified, adjacent to the C-terminus (Lupas, 1997; Lupas et al., 1991).
Electron micrographic immune-labeling studies suggest that both the N- and C- termini,
which comprise a large portion of the soluble regions and the overall majority of the protein,
are localized within the matrix (Martell et al., 2012). To identify a well-folded domain and
structural target within the matrix-oriented region of MCU, I performed a multiple
sequence alignment of roundworm, fruit fly, fish, human and mouse sequences (Fig. 3.2)
(Sievers & Higgins, 2014). Based on the conserved sequence among these species outside
the putative TM and CC domains, I cloned a construct encompassing residues 72 to 189
(i.e. MCU72-189). Far-UV circular dichroism (CD) spectroscopy was used to assess the
secondary structure and showed that MCU72-189 is comprised of an α-helix/β-strand mixture
(Fig. 3.3A). An assessment of stability was made by monitoring the change in CD signal at
222 nm as a function of temperature. This thermal melt showed that MCU72-189
cooperatively unfolds with a midpoint of temperature denaturation (Tm) above 60°C (Fig.
3.3B), indicating a stably folded domain.
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Figure 3.1. Domain architecture and structural features of MCU. Domain
architecture of human MCU (NCBI, Q8NE86). Residue ranges and the prevailing
topology are indicated at top. Signal peptide (SP, teal), transmembrane domain (TM1,
TM2, red) and coiled-coil domain (CC1, CC2, yellow) were predicted
bioinformatically (Emanuelsson et al., 2000; Krogh et al., 2001; Lupas, 1997).
MCU105-189 and MCU72-189 constructs studied herein are indicated (blue).
9
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Figure 3.2. Multiple sequence alignment of MCU from various organisms. C.
elegans (C.) (NCBI, NP_500892.1), B. dorsalis (B.) (NCBI, XP_011204677.1), D.
rerio (D.) (NCBI, NP_001070793), G. gallus (G.) (NCBI, XP_015143713.1), H.
sapiens (H.) (NCBI, NP_612366.1) and M. musculus (M.) (NCBI, NP_001028431)
sequences were aligned in Clustal Omega using the default settings (Sievers &
Higgins, 2014). Residue numbers are indicated at the right. Below the alignment, the
(*) indicates fully conserved residues, (:) strongly similar residues, and (.) weakly
similar residues. For the H. sapiens sequence, residue ranges corresponding to the
domains shown in Fig. 3.1 are shaded the corresponding colour (signal peptide= teal,
CC1 & CC2= yellow, TM1 & TM2= red). The residues shaded in green correspond
to MCU72-189. The fully-conserved R93 and E95 residues forming a salt bridge are
bound by boxes.
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Figure 3.3. Secondary structure and stability of MCU72-189. (A) Far-UV CD
spectrum of MCU72-189. α-helices are represented by negative ellipticity at ~208 and
222 nm, β-sheets are represented by negative ellipticity at ~215 nm, and random coils
are represented by negative ellipticity at ~200 nm. The far-UV CD spectrum of
MCU72-189 reveals a mixture of α-helices, β-sheets and random coil conformations.
(B) Thermal stability of MCU72-189. The change in far-UV CD ellipticity at 222 nm
was taken as an indicator of thermal stability. The apparent temperature where the
fractional change in ellipticity ≈ 0.5 (Tm) is ~65°C. Data is the average of three
separate experiments (n=3) and acquired using 0.5 mg mL-1 protein in 20 mM Tris,
150 mM NaCl, 1 mM DTT, pH 8.0.
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With MCU72-189 being a stably folded domain, I proceeded to crystallize MCU72-189 to solve
its structure by first identifying conditions for crystallization of the WT MCU72-189. These
conditions were identified by performing initial sparse matrix screens, which contain
conditions that proved to be successful for previous macromolecules, followed by further
optimization of the crystal conditions. Since there was no available template structure to
solve the phasing by molecular replacement, I crystallized an I141M/L146M MCU72-189
double mutant for selenomethionine (Se-Met) incorporation. Afterwards, the phase
problem of the double mutant was solved by anomalous diffraction in collaboration with
the M. Junop laboratory (Department of Biochemistry, Western University). With the
crystal structure of the double mutant in hand, I then solved the crystal structure of the
human native MCU72-189 protein under three different solution conditions by molecular
replacement in collaboration with the M. Junop laboratory (Table 2).
The native WT structure, with a good resolution of 1.6 Å, revealed two central α-helices
approximately perpendicular to one another, in between two three-stranded β-sheets (Fig.
3.4). The first β-sheet is arranged in an antiparallel manner, formed with three β-strands
(β1; residues 76-80, β2; residues 83-88 and β3; residues 97-100). The β-strands are linked
by one short loop (i.e. L1; residues 81-82) and one long loop (i.e. L2; residues 89-96).
Furthermore, a salt bridge between the NH1 atom of R93 and the O1 atom of E95
stabilizes the L2 conformation (Fig. 3.5) (Costantini et al., 2008). This salt bridge is in
close proximity to a single Cys (i.e. C97) as well as a known phosphorylation site (i.e. S92),
which may act to stabilize the loop for post-translational modifications of these residues
(Joiner et al., 2012; Lee et al., 2015). Additionally, L3 (i.e. residues 101-107) connects a
centrally located α1 helix (i.e. residues 108-118) to the N-terminal β-sheet. Located Cterminal to the central α1 helix is the second β-sheet, formed with three β-strands in an
antiparallel orientation (β4; residues 125-128, β5; residues 149-153 and β6; residues 156160). A short α-helix (i.e. α2; residues 141-146) that is perpendicular to α1 and also
centrally positioned relative to the two β-sheets separates the β4 and β5 strands. This short
α-helix is linked to the β4 and β5 strands through one long loop (i.e. L5; residues 129-140)
and one short loop (i.e. L6; residues 147-148). Residues 168-189 of the C-terminal region
of MCU72-189 do not show any appreciable electron density, suggesting that the C-terminal
tail is dynamic under these conditions.
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Table 2. Crystallographic data and refinement statistics.
I141M/L146M
MCU72-189
(Se-Met)

MCU72-189
(MgCl2)

MCU72-189
(LiSO4)

MCU72-189
(CaCl2)

48.06-1.5

68.98-1.6

48.13-1.5

71.71-2.7

(1.53-1.5)

(1.63-1.6)

(1.53-1.5)

(2.85-2.7)

19352

15893

19303

2858

11.3 (11.2)

11 (7.4)

11.4 (11.3)

5.4 (5.5)

Data Collection:
Resolution range (Å)
Unique reflections
Redundancy
Anomalous redundancy

5.4 (5.2)

Mean (I/σI)

15.1 (3.4)

17.6 (3.2)

13.2 (4.9)

12.8 (3.5)

Rmerged (%)

9.4 (106.1)

8.5 (63)

14.3 (163.6)

8.6 (43.8)

Completeness (%)

100 (100)

99.9 (99.4)

99.5 (98.9)

100 (100)

Anomalous completeness

100 (100)

Unit cell

55.5, 55.5,

55.36, 55.36,

55.57, 55.57,

51.28, 51.28,

69.02

68.98

69.04

71.71

90, 90, 120

90, 90, 120

90, 90, 120

90, 90, 120

Space group

P65

P65

P65

P65

Mosaicity

0.23

0.41

0.22

1.05

Wilson B

18.5

17.4

11.7

61

Resolution range (Å)

39.4-1.5

47.9-1.6

39.5-1.5

37.8-2.7

Rwork/Rfree (%)

20.4/21.8

17.2/20

18.5/20.7

27.3/30

Refl. observed

19312

15608

19107

2837

Refl. test set

1953

1560

1915

282

Protein atoms

736

745 [+1 Mg2+]

730

730

Solvent atoms

87 water, 8 Tris

148 water

131 water

15 water

Rmsd bond lengths (Å)

0.008

0.005

0.005

0.004

Rmsd bond angles (°)

1.103

0.830

0.772

0.620

Wilson B

16.92

14.61

14.1

None given

Angles

Model and refinement:

Note: values in parenthesis are for the highest resolution shell
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Figure 3.4. Ribbon view of the backbone structure of MCU72-189. The -strands
(1-6, arrows) and loop regions (L1-L6) are colored green while the -helices (1,
2) are colored blue. The critical L2 region where the phosphorylation site, salt
bridge and single Cys residue are found are bound by the broken box.
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Figure 3.5. Zoomed view of L2. The R93 and E95 side chains forming an
intramolecular salt bridge (Costantini et al., 2008) are shown as red and blue sticks,
respectively. The L2 C97 and S92 residues that may undergo post-translational
modifications are shown as yellow sticks.
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Overall, the tertiary structure of MCU72-189 hides 33 residues that are at least 85% solvent
inaccessible (Cavallo et al., 2003). In fact, the majority of these side chains are directed
toward the inner core of the structure. On the contrary, residues V85 and V152, which are
centrally located on each of the β-sheets, respectively, are directed away from the inner
core (Fig. 3.6). These two residues may play roles in mediating protein-protein interactions
and/or stabilizing the β-sheets at a more local level. When viewing the electrostatic surface
of the protein, a prominent negative patch near the C-terminal face is shown, with residues
D131, D142, D147, D148 and D166 contributing the majority of the acidic charge in this
region (Fig. 3.7). A second negative patch closer to the N-terminal face of the protein is
primarily comprised of residues E117, E118, E119, D124 and D155. Furthermore, two
basic patches on the protein surface are comprised of residues R89, R93, R94 and R96, in
addition to residues R113, R124 and R134, respectively (Fig. 3.7). The large degree of
surface charge polarity exhibited by MCU72-189 may facilitate a relationship for higher order
assembly of the domain.
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Figure 3.6. Hydrophobic core of MCU72-189. Surface representation of MCU72-189
(white) with residues that are at least 85% solvent inaccessible are shown as sticks
(green) that were calculated using Parameter OPtimsed Surfaces (POPS) (Cavallo et
al., 2003). The V85 and V152 side chains (red) that are directed away from the core,
centrally located on each β-sheet, are indicated.
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Figure 3.7. Electrostatic surface potential of MCU72-189. The electrostatic potential
was calculated by solving the Poisson-Boltzmann equation using the APBS and
PDB2PQR tools (Baker et al., 2001; Dolinsky et al., 2007). The gradient shown is
from −2 (acidic, red) to +2 (basic, blue) kT/e. Locations of only the surface charge
acidic and basic residues are shown.
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A DALI search for similar folds, performed by the DALI server which is a network service
for comparing protein structures in 3D (Holm & Rosenstrom, 2010), revealed that the
closest known structural homologue to MCU72-189 is ubiquitin-like protein 5 (ULP5), which
also adopts a β-grasp fold. Although the sequence identity between the crystallized region
of ULP5 and MCU72-189 is only ~5%, the backbone root mean square deviation (RMSD)
between the two proteins is 3.0 Å (Fig. 3.8). Although MCU72-189 conforms to the core βgrasp structure consisting of a central α-helix that packs diagonally against a β-sheet with
parallel and central N- and C-terminal β-strands (Burroughs et al., 2007), it also contains
unique differences from the core β-grasp structure. First, MCU72-189 contains a
discontinuous sheet that is split into two halves, which is due to lack of hydrogen (H)bonding between the central β1 and β6 strands. Additionally, a third β-strand is placed in
the N-terminal sheet (i.e. β3) prior to the central helix, which changes the orientation of α1
by ~90°. Lastly, a short α-helix is located between β4 and β5, capping one end of the
structure. The observed β-grasp-like fold of MCU72-189 is unlikely to be caused by
expressing a small region of a larger protein, since exclusion of the first two β-strands (i.e.
leaving a 4-stranded core with the N- and C-terminal strands parallel) results in a
destabilized conformation (Fig. 3.9).
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Figure 3.8. Structural alignment of MCU72-189 and ULP5. ULP5 (4pyu.pdb) was
identified by DALI (Holm & Rosenstrom, 2010) as the closest structural homologue
to MCU72-189. The backbone alignment for ULP5 (black ribbon) and MCU72-189
(green and blue ribbon) are shown with a 3.0 Å RMSD between the two proteins over
74 residues, despite only 5% sequence identity.
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Figure 3.9. Secondary structure and stability of MCU105-189. (A) Far-UV CD
spectrum of MCU105-189. α-helices are represented by negative ellipticity at ~208 and
222 nm, β-sheets are represented by negative ellipticity at ~215 nm, and random coils
are represented by negative ellipticity at ~200 nm. The far-UV CD spectrum of
MCU105-189 reveals a mixture of α-helices, β-sheets and random coil conformations.
Relative to MCU72-189, the far-UV CD spectrum of MCU105-189 reveals a shift to a
lower wavelength in the 208 nm peak as well as less negativity at ~215 and ~222 nm,
indicating more protein disorder. (B) Thermal stability of MCU105-189. The change in
far-UV CD ellipticity at 222 nm was taken as an indicator of thermal stability. The
apparent temperature where the fractional change in ellipticity ≈ 0.5 (Tm) is ~39°C,
which is ~26°C less stable than MCU72-189. The cooperativity of the curve is also
decreased, indicating that MCU105-189 exists as a less compact and folded structure
relative to MCU72-189. Data is the average of three separate experiments (n=3) and
acquired using 0.5 mg mL-1 protein in 20 mM Tris, 150 mM NaCl, pH 8.0.
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3.2

The β-grasp-like domain of MCU interacts with Mg2+ and Ca2+

MCU72-189 was successfully crystallized in the presence of MgCl2, and under these
crystallization conditions, a Mg2+ atom was found near the negatively charged D131, D147
and D148 side chains, which are primary contributors to the major acidic surface patch (Fig.
3.10A). D147 side chain atoms O1 and O2 are within 3.5 and 2.1 Å, respectively, of the
centrally located Mg2+ ion in the acidic patch. On the other hand, the D131 and D148 side
chains are positioned further away (i.e. minimum O distance ~6.6 Å) (Fig. 3.10B). The
Mg2+ ion is coordinated by the D147 O2 atom and five water molecules arranged in an
octahedral geometry (Fig. 3.11). The arrangement of the five ligand water molecules and
the D147 carboxylate surrounding the Mg2+ is visible in the 2Fo-Fc electron density map
contoured at 2.0. Furthermore, an Fo-Fc omit map contoured at 9.0 shows the
unaccounted for electron density when the Mg2+ atom is not modeled into the structure (Fig.
3.11).
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A

B
D166
D166
Mg2+

D148
D147
Mg2+
45°

D131

30°
D147
D131
D148

Figure 3.10. Mode of Mg2+ binding to MCU72-189. (A) Location of the Mg2+ atom
(yellow sphere) relative to the backbone structure (ribbon view) and acidic side
chains (red sticks) contributing to the prominent negative patch on MCU72-189. The
broken box demarcates the acidic patch region. Closest distances from the Asp side
chains of D131, D147 and D148 to the Mg2+ atom are 6.6 Å, 2.1 Å and 6.6 Å,
respectively. (B) Enlarged view of the acidic patch shown in (A). The Mg2+ atom
(yellow sphere) centrally located in the acidic patch is shown.
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H2O
2Fo-Fc: 2.0σ
Fo-Fc: 9.0σ D131

2.2 Å
2.1 Å

D148

10.5 Å

9.0 Å
5.0 Å

2.1 Å

2.3 Å
2.1 Å
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D147

Figure 3.11. Mg2+ atom coordination geometry. The 2Fo-Fc (2.0 ) electron density
map (grey mesh) is shown with the modeled protein chain (sticks), water molecules
(blue spheres) and the Mg2+ atom (yellow sphere). The Fo-Fc (9.0 ) omit map
(magenta mesh) shows a distinct, unaccounted for density in the absence of the Mg2+
atom. Distances between the Asp (red sticks) C atoms are indicated. The octahedral
coordination of Mg2+ between the D147 O1 and five water molecules is shown with
oxygen atom distances indicated. The electron density map was created using CCP4
software (Winn et al., 2011).
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In addition to MgCl2, MCU72-189 was also successfully crystallized with either LiSO4 or
CaCl2 (Table 2). In the presence of LiSO4 (1.5 Å), the Fo-Fc omit map contoured at 2.5
shows no unaccounted for electron density in the acidic patch, demonstrating electron
density associated with the atom only in the presence of MgCl2 (Fig. 3.12). In the presence
of CaCl2, the crystallized structure showed much lower resolution than the MgCl2 or LiSO4
structures (i.e. 2.7 Å versus 1.5-1.6 Å), and hence, a Ca2+ atom could not be reliably located.
The lack of a Ca2+ atom may be due to the lower resolution, as well as a twining problem
associated with this crystal structure, contributing to lower data quality. However, all three
backbone structures are very similar to one another (Fig. 3.13).
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2Fo-Fc: 2.0σ
Fo-Fc: 2.5σ
D131
D148

10.6 Å
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D147

4.8 Å

Figure 3.12. Electron density map of MCU72-189 solved in the presence of LiSO4.
The 2Fo-Fc (2.0 ) map (grey mesh) of the same region shown in Fig 3.11 does not
exhibit evidence for a cation, and the Fo-Fc (2.5 ) map (magenta mesh) shows no
unaccounted for density. The electron density map was created using CCP4 software
(Winn et al., 2011).
MgCl2
CaCl2
LiSO4

Figure 3.13. Ribbon view of the backbone alignments of MCU72-189 structures.
The structures were solved in the presence of MgCl2 (green), CaCl2 (yellow) and
LiSO4 (red). Structural alignments were performed with Theseus (Theobald &
Wuttke, 2008).
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With the discovery of a Mg2+ ion bound to MCU72-189 in the crystal state, I then proceeded
to characterize the cation binding in solution. I used changes in MCU72-189 intrinsic
fluorescence to monitor structural changes associated with Mg2+ or Ca2+ binding. In
divalent cation-free conditions and using an excitation wavelength (ex) of 280 nm,
MCU72-189 showed an intrinsic fluorescence emission maximum at a wavelength (em) of
~305 nm. This is consistent with Tyr fluorescence and the absence of Trp in the domain
(Preston & Phillips, 2016). Furthermore, addition of 5 mM MgCl2 or CaCl2 decreased the
intrinsic fluorescence of MCU72-189 (Fig. 3.14A and 3.14B), in which a systematic decrease
in intrinsic fluorescence was observed upon increasing concentrations of MgCl2 or CaCl2.
It was also revealed that guanidine-induced denaturation decreased the intrinsic
fluorescence of MCU72-189, which may suggest that the fluorescence change observed in
the MgCl2 and CaCl2 titrations reflect some loss in structure associated with cation binding
(Fig. 3.14C). Plots of the changes in fluorescence intensity at the wavelength showing
maximum fluorescence change (i.e. ex=280 nm; em=302 nm) versus MgCl2 or CaCl2
showed saturable binding of Mg2+ and Ca2+. After fitting the binding curves to a one-site
binding model that takes into account protein concentration, apparent equilibrium
dissociation constants for Mg2+ (KD,Mg2+) and Ca2+ (KD,Ca2+) were found to be ~1.7 and ~2.3
mM, respectively (Fig. 3.15).
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Figure 3.14. Cation-dependent intrinsic fluorescence changes and chemical
denaturation of MCU72-189. (A) Fluorescence emission spectra of MCU72-189 in the
absence (black circles) and presence (blue circles) of 5 mM MgCl2. The difference
spectrum (i.e. 5 mM MgCl2 spectrum - 0 mM MgCl2 spectrum) is shown (red
circles). (B) Fluorescence emission spectra of MCU72-189 in the absence (black
circles) and presence (orange circles) of 5 mM CaCl2. The difference spectrum (i.e. 5
mM CaCl2 spectrum - 0 mM CaCl2 spectrum) is shown (red circles). Data in (A) and
(B) are the average of three separate experiments (n=3) acquired using 0.5 mg mL-1
protein in 20 mM HEPES, 150 mM KCl, 2 mM DTT, pH 7.5, 25°C and an excitation
wavelength (ex) of 280 nm. Error bars represent SEM. (C) Guanidine induced
denaturation of MCU72-189 monitored by changes in intrinsic fluorescence. Changes
in intrinsic fluorescence using ex=275 nm and em=305 nm are plotted versus
guanidine-HCl concentration. The guanidine concentration-dependent decrease in
fluorescence is indicative of MCU72-189 unfolding. Data is the average of three
separate experiments (n=3) acquired using 0.2 mg mL-1 protein in 20 mM HEPES,
150 mM KCl, 2 mM DTT, pH 7.5 at 25°C. Error bars represent SEM.
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Figure 3.15. Effect of cations on MCU72-189 intrinsic fluorescence. Changes in
intrinsic fluorescence as a function of MgCl2 (A) and CaCl2 (B) concentrations at
25°C. Data were fitted to a one-site binding curve (red line) taking into account
protein concentration. Data is the average of three separate experiments (n=3)
acquired using 0.5 mg mL-1 protein in 20 mM HEPES, 150 mM KCl, 2 mM DTT, pH
7.5. Error bars represent SEM.
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To evaluate whether Mg2+ or Ca2+ binding to MCU72-189 influences secondary structure or
stability in solution, I assessed the far-UV CD spectrum of the protein as a function of
increasing Mg2+ or Ca2+ levels. It was found that cation binding to MCU72-189 does not
appreciably alter secondary structure, as increasing concentrations of Mg2+ or Ca2+
minimally changed the far-UV CD ellipticity (Fig. 3.16). The effects on MCU72-189 stability
were also evaluated through changes in far-UV CD signal at 222 nm as a function of
temperature in the presence and absence of MgCl2 or CaCl2. In the absence of cations,
MCU72-189 had an apparent Tm of ~66°C. Addition of 40 mM MgCl2 to the protein
decreased the Tm of MCU72-189 to ~62°C (Fig. 3.17A). Remarkably, addition of 40 mM
CaCl2 destabilized the protein to a greater extent than MgCl2, resulting in a Tm value of
~59°C (Fig. 3.17B).
Altogether, results from the crystal structures, solution far-UV CD spectroscopy and
intrinsic fluorescence suggest that MCU72-189 binds Mg2+ and Ca2+ with ~mM affinity on
an acidic region of the protein surface, resulting in destabilization of the domain.
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Figure 3.16. Secondary structure of MCU72-189. Effects of MgCl2 (A) and CaCl2 (B)
on MCU72-189 secondary structure. Shown are the far-UV CD spectra in the absence
(black line) and presence of 40 mM MgCl2 (red line) or CaCl2 (blue line) acquired at
4°C. Data is the average of three separate experiments (n=3) acquired using 0.5 mg
mL-1 protein in 20 mM HEPES, 150 mM KCl, 2 mM DTT, pH 7.5.
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Figure 3.17. Stability of MCU72-189. MCU72-189 stability sensitivity to MgCl2 (A) and
CaCl2 (B). Stability was assessed from changes in ellipticity as a function of
temperature in the absence (black circles) and presence of 40 mM MgCl2 (red circles)
or CaCl2 (blue circles). Data is the average of three separate experiments (n=3) and
acquired using 0.5 mg mL-1 protein in 20 mM HEPES, 150 mM KCl, 2 mM DTT, pH
7.5. Error bars represent SEM.
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3.3

Ca2+ promotes MCU72-189 monomerization and weakens self-association

With relatively small secondary structural changes associated with Mg2+ or Ca2+ binding, I
proceeded to determine if other factors might contribute to the destabilization due to cation
binding. AUC was performed to assess the quaternary structure of MCU72-189. After
globally fitting the equilibrium data to a single ideal species, molecular weights of ~22.3,
21.5 and 18.5 kDa for samples prepared at 1.2, 0.8 and 0.4 mg mL-1, respectively, were
revealed (Fig. 3.18A, 3.18B and 3.18C; Table 3). Moreover, these fitted molecular weights
corresponded to 1.6, 1.5 and 1.3× the theoretical monomeric mass of ~13.9 kDa, indicating
a concentration dependence and fast exchange equilibrium. This fast exchange equilibrium
is indicated by the equilibrium data with MWs between the monomer and dimer theoretical
masses. Due to the larger destabilization of MCU72-189 caused by Ca2+ compared to Mg2+,
I then performed AUC of MCU72-189 in the presence of 40 mM CaCl2. After global fitting
of the equilibrium data to a single ideal species, CaCl2 was shown to decrease the fitted
molecular weights to ~20.0, 18.8 and 16.2 kDa, corresponding to 1.4, 1.4 and 1.2× the
theoretical monomeric mass for the 1.2, 0.8 and 0.4 mg mL-1 datasets, respectively (Fig.
3.18D, 3.18E and 3.18F; Table 3). Therefore, CaCl2 appears to shift the monomer-dimer
equilibrium of MCU72-189 toward monomer.
Another reason I performed AUC was to quantify the strength of the self-association of
MCU72-189 in the presence and absence of CaCl2. After globally fitting the equilibrium data
to a monomer-dimer equilibrium model, the apparent equilibrium dissociation constants
for the monomer-dimer equilibrium (KD,dimer) were determined at the three protein
concentrations. Apparent KD,dimer values of MCU72-189 were 58.6, 77.9 and 126 M for the
1.2, 0.8 and 0.4 mg mL-1 datasets, respectively (Fig. 3.19A, 3.19B and 3.19C; Table 3).
Global fitting of the 40 mM CaCl2 equilibrium data to a monomer-dimer equilibrium model
was also performed. In the presence of 40 mM CaCl2, the globally fitted apparent KD,dimer
values were 139, 197 and 369 M. These values are ~2× higher than the apparent KD,dimer
values measured in the absence of CaCl2, indicating weaker affinity for self-association
(Fig. 3.19D, 3.19E and 3.19F; Table 3). Therefore, CaCl2 weakens the affinity of
MCU72-189 self-association.
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Figure 3.18. Equilibrium ultracentrifugation molecular weight analysis of
MCU72-189 in the absence and presence of CaCl2. Sedimentation equilibrium of
MCU72-189 in the absence of CaCl2 at 1.4 mg mL-1 (A), 0.8 mg mL-1 (B) and 0.4 mg
mL-1 (C). Data were acquired at 18,000, 21,000 and 25,000 rpm at 25°C. The red
lines through the data are from a global single ideal molecular weight fit within each
respective panel. The residuals for the fits are shown on the top of each panel.
Sedimentation equilibrium of MCU72-189 in the presence of 40 mM CaCl2 performed
at 1.4 mg mL-1 (D), 0.8 mg mL-1 (E) and 0.4 mg mL-1 (F). Data were acquired at
18,000, 21,000 and 25,000 rpm at 25°C. The orange lines through the data are from a
global single ideal molecular weight fit within each respective panel. The residuals
for the fits are shown on the top of each panel. Data in all panels were acquired in 20
mM HEPES, 150 mM KCl, 2 mM DTT, pH 7.5 at 25°C.
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Figure 3.19. Equilibrium ultracentrifugation self-association analysis of
MCU72-189 in the absence and presence of CaCl2. Sedimentation equilibrium of
MCU72-189 in the absence of CaCl2 at 1.4 mg mL-1 (A), 0.8 mg mL-1 (B) and 0.4 mg
mL-1 (C). Data were acquired at 18,000, 21,000 and 25,000 rpm at 25°C. The red
lines through the data are from a monomer-dimer equilibrium fit within each
respective panel. The residuals for the fits are shown on the top of each panel.
Sedimentation equilibrium of MCU72-189 in the presence of 40 mM CaCl2 performed
at 1.4 mg mL-1 (D), 0.8 mg mL-1 (E) and 0.4 mg mL-1 (F). Data were acquired at
18,000, 21,000 and 25,000 rpm at 25°C. The orange lines through the data are from a
monomer-dimer equilibrium fit within each respective panel. The residuals for the
fits are shown on the top of each panel. Data in all panels were acquired in 20 mM
HEPES, 150 mM KCl, 2 mM DTT, pH 7.5 at 25°C.
Table 3. Molecular weights and dimerization affinities as determined from AUC
data.
[protein]
(mg mL-1)

CaCl2a

MW
(Da)b

SE

Stoichiometryc

R2d

KD,
Dimere
(mM)

SE

R2d

1.2
0.8
0.4

-

22851
21465
18543

226
227
346

1.65
1.55
1.34

0.998
0.998
0.995

0.059
0.078
0.126

0.007
0.008
0.019

0.998
0.998
0.995

1.2
0.8
0.4

+
+
+

20013
18748
16283

226
276
369

1.44
1.35
1.17

0.998
0.997
0.994

0.139
0.197
0.369

0.013
0.023
0.080

0.998
0.998
0.994

aAcquired

in the absence (-) or presence (+) of 40 mM CaCl2.
fitted single ideal molecular weights from data acquired at 18,000, 21,000
and 25,000 rpm.
cFitted molecular weight/theoretical monomeric molecular weight (i.e. 13,864 Da).
dCorrelation coefficient from global fits.
eGlobally fitted monomer-dimer equilibrium dissociation constants from data
acquired at 18,000, 21,000 and 25,000 rpm.
SE, standard error.
bGlobally
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3.4

Acidic patch mutations destabilize MCU72-189 similar to metal binding

To confirm that MCU72-189 destabilization induced by Ca2+ and Mg2+ is due to interactions
with the acidic patch, I introduced D131R or D147R substitutions and evaluated the effects
of CaCl2 and MgCl2 on thermal stability. Residue D131 is found within ~9.0 Å of D147
(i.e. C) on the loop immediately after the 4 strand, with D147 adjacent to the C-terminal
end of the α2 helix (Fig. 3.10A). Similar to the WT MCU72-189, Mg2+ or Ca2+ binding to
both MCU72-189 D131R and D147R did not appreciably alter secondary structure, as shown
by minimal changes in far-UV CD ellipticity (Figure 3.20). Compared to the native protein
with a Tm value of ~66°C, the D147R and D131R mutant proteins exhibited Tm values of
~61°C (~-5°C) and ~57°C (~-9°C), respectively. This indicates that, despite the looplocalization of the D147 and D131 residues, incorporation of a positively charged residue
in the acidic patch markedly destabilizes the domain (Fig. 3.21). When MCU72-189 D147R
was supplemented with 40 mM MgCl2 or CaCl2, the Tm value decreased by ~2°C. This
smaller change is in contrast to the ~4°C and ~7°C destabilization observed for native
MCU72-189 by MgCl2 and CaCl2, respectively (Fig. 3.21A; Table 4). Likewise, a smaller
destabilization compared to native MCU72-189 was also observed for MCU72-189 D131R (i.e.
~-0°C and ~-3°C, respectively) (Fig. 3.21B; Table 4). Therefore, incorporating the
MCU72-189 mutations in the acidic patch resulted in a domain destabilization (i.e. ∆Tm
between ~-5 and -10°C), which is similar to the destabilization caused by Ca2+ and Mg2+
binding to native MCU72-189 (i.e. ∆Tm between ~-4 and -7°C). Furthermore, these mutations
attenuated the effects of divalent cation binding on MCU72-189 stability. These data suggest
that incorporation of a basic charge into the acidic patch via mutation destabilizes
MCU72-189 similar to the binding of cations in this region and suppresses any further
destabilization caused by interactions with Mg2+ or Ca2+.
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Figure 3.20. Secondary structure of MCU72-189 D131R and D147R. Effects of
MgCl2 and CaCl2 on MCU72-189 D147R (A) and D131R (B) secondary structure.
Shown are far-UV CD spectra in the absence (black line) and presence of 40 mM
MgCl2 (red line) or CaCl2 (blue line) acquired at 4°C. Data is the average of three
separate experiments (n=3) acquired using 0.5 mg mL-1 protein in 20 mM HEPES,
150 mM KCl, 2 mM DTT, pH 7.5.
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Figure 3.21. Stability of native MCU72-189, MCU72-189 D131R and D147R. (A)
Changes in far-UV CD ellipticity as a function of temperature for native MCU72-189
(black circles) and MCU72-189 D147R (blue circles) in the presence of 40 mM MgCl2
(red circles) or 40 mM CaCl2 (yellow circles). (B) Changes in far-UV CD ellipticity
as a function of temperature for native MCU72-189 (black circles) and MCU72-189
D131R (blue circles) in the presence of 40 mM MgCl2 (red circles) or 40 mM CaCl2
(yellow circles). The control data are the same in both (A) and (B). Data were
acquired together but are separated into (A) and (B) for clarity. Data is the average of
three separate experiments (n=3) acquired using 0.5 mg mL-1 protein in 20 mM
HEPES, 150 mM KCl, 2 mM DTT, pH 7.5. Error bars represent SEM.
Table 4. Stability of mutant and native MCU72-189 in the presence and absence
of MgCl2 or CaCl2.
Protein

Tm,apoa
(°C)

SE

Tm,Mg2+b
(°C)

SE

Tm,Ca2+c
(°C)

SE

Native
D147R
D131R

66.0
61.0
57.0

±0.02
±0.04
±0.05

62.0
59.0
57.0

±0.03
±0.04
±0.06

59.0
59.0
54.0

±0.04
±0.04
±0.09

Protein

∆Tm,mutantd
(°C)

SEe

∆Tm,Mg2+f
(°C)

SEe

∆Tm,Ca2+g
(°C)

SEe

Native
D147R
D131R

N/A
-5.0
-9.0

N/A
±0.04
±0.05

-4.0
-2.0
0.0

±0.04
±0.06
±0.08

-7.0
-2.0
-3.0

±0.04
±0.06
±0.10

aAverage

of three separate thermal melts in the absence of MgCl2 and CaCl2 (i.e.
apo).
bAverage of three separate thermal melts in the presence of MgCl
2.
cAverage of three separate thermal melts in the presence of CaCl
2.
dT
m,mutant(apo)-Tm,native(apo).
ePropagated error.
fT
m,Mg2+-Tm,apo.
gT
m,Ca2+-Tm,apo.
SE, standard error.
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3.5

Mutation in the MCU72-189 acidic patch attenuates Ca2+-dependent

monomerization
In addition to AUC, I also performed SEC-MALS to assess the quaternary structure of
MCU72-189 and to confirm the tendency for MCU72-189 dimerization. The protein eluted as
a single major peak on a Superdex 200 10/300 GL column with an apparent MW of ~24.6
kDa, equal to 1.77× the theoretical 13.9 kDa monomeric mass (Fig. 3.22, Table 5). Given
the globular structure of MCU72-189, this data suggests the presence of a monomer-dimer
equilibrium in fast exchange, consistent with the AUC data. When SEC-MALS was
performed in the presence of 40 mM CaCl2, the apparent MW of MCU72-189 was ~17.9 kDa,
equal to 1.29× the theoretical monomeric mass (Fig 3.22, Table 5). Therefore, consistent
with the AUC findings, the SEC-MALS data show a shift in the monomer-dimer
equilibrium of MCU72-189 toward monomer in the presence of CaCl2.
With residue D147 being one of the major contributors to the formation of the contiguous
acidic patch, I introduced a D147R substitution and assessed its effects on MCU72-189
quaternary structure by SEC-MALS. The protein eluted as a single major peak on a
Superdex 200 10/300 GL column with an apparent MW of ~16.0 kDa, equal to 1.15× the
theoretical monomeric mass of ~13.9 kDa (Fig 3.22, Table 5). SEC-MALS of MCU72-189
D147R in the presence of 40 mM CaCl2 revealed an apparent MW of ~15.8 kDa, 1.14× the
theoretical monomeric mass of ~13.9 kDa (Fig 3.22, Table 5). Therefore, with the
incorporation of the D147R mutation, the monomer-dimer equilibrium of MCU72-189 is
persistently shifted toward monomer. Consistent with the constitutive monomeric state,
CaCl2 has minimal effect on the oligomerization state.
Taken together, the AUC and SEC-MALS data demonstrate that MCU72-189 exists in a
monomer-dimer equilibrium with sub-mM affinity undergoing fast exchange. Importantly,
CaCl2 weakens MCU72-189 self-association by ~2-3 fold, and disruption of the acidic patch
by mutation promotes monomerization similar to cation binding.
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Figure 3.22. SEC-MALS analysis of MCU72-189 and MCU72-189 D147R. Relative
changes in UV 280 absorbance and MW (Da) of native MCU72-189 (A) and MCU72-189
D147R (B) are plotted as a function of elution volume (mL). Shown are their
respective peaks in the absence of CaCl2 (black line) and in the presence of CaCl2
(red line). Over the peak region, the MW of the species in the absence of CaCl2
(black circles) and in the presence of CaCl2 (red circles) is calculated from the light
scattering measurements. The MW of each peak is shown on the right of each peak
with SE. Data are representative of three separate experiments (n=3) for each plot,
acquired using 2.0 mg mL-1 protein in 20 mM HEPES, 150 mM KCl, 0.5 mM DTT,
pH 7.5.
Table 5. Ca2+ dependence of MCU72-189 and MCU72-189 D147R MWs measured by
SEC-MALS.
Protein

Repetition

CaCl2a

MW (kDa)b

SE

Stoichiometryc

Native MCU72-189

1
2
3
Average

-

21.8
29.4
22.6
24.6

0.7
1.7
1.1
1.2

1.57
2.12
1.63
1.77

Native MCU72-189

1
2
3
Average

+
+
+
+

15.8
17.6
20.2
17.9

2.3
3.6
1.9
2.6

1.14
1.27
1.45
1.29

MCU72-189 D147R

1
2
3
Average

-

15.9
15.6
16.4
16.0

1.1
0.6
0.7
0.8

1.14
1.12
1.18
1.15

MCU72-189 D147R

1
2
3
Average

+
+
+
+

16.8
15.4
15.2
15.8

2.2
1.0
0.7
1.3

1.21
1.11
1.09
1.14

aAcquired

in the absence (-) or presence (+) of 40 mM CaCl2.
weights calculated from ASTRA software v.6.1.5.22 (Wyatt Technologies).
cFitted molecular weight/theoretical monomeric molecular weight (i.e. 13.9 kDa).
SE, standard error.
bMolecular
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Altogether, I have discovered that MCU contains a conserved β-grasp-like matrix domain
that weakly interacts with the divalent cations Mg2+ and Ca2+. Furthermore, Ca2+ not only
promotes MCU72-189 monomerization, but also weakens its tendency to self-associate.
D131R and D147R mutations in the acidic patch destabilize MCU72-189 similar to metal
binding and also attenuate the sensitivity of stability to the presence of Mg2+ and Ca2+.
Lastly, incorporation of a D147R mutation in the cation binding region induces
monomerization of MCU72-189 even in the absence of Ca2+.
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Chapter 4

Discussion
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4.1

Significance of the MCU72-189 β-grasp-like fold

Proteins that adopt β-grasp folds such as ubiquitin are known to be involved in a diverse
range of biochemical functions, such as providing a scaffold for different enzymatic active
sites, assembly of macromolecular complexes and also for post-translational protein
modification (Burroughs et al., 2007). Furthermore, they are known to interact with nucleic
acids, proteins and metal ions (Burroughs et al., 2007; Burroughs et al., 2012). In fact, the
eukaryotic ubiquitin superfamily has diversified into at least 67 distinct families (Burroughs
et al., 2007). Therefore, given the large structural diversity of -grasp proteins, the
variations observed for the -grasp-like fold of MCU72-189 are not surprising. -grasp
proteins can include as many as ten or as few as three -strands and up to three α-helices
with the central α-helix crossing in either direction (Burroughs et al., 2007; Burroughs et
al., 2012). For example, the streptococcal immunoglobulin-binding protein G and the
staphylococcal enterotoxin B are dominated by a -sheet with five anti-parallel -strands
and a single helical segment (Kraulis, 1991; Murzin et al., 1995). With regards to
MCU72-189, I have found that its -grasp-like fold not only plays a role as a proteininteraction domain through self-association tendencies, but also has an intrinsic ability to
bind the divalent cations Ca2+ and Mg2+. Interestingly, this N-terminal region of MCU was
also recently shown by co-immunoprecipitation assays to associate with MCUR1, an
important MCU regulator (Lee et al., 2015).

4.2

Differences between MCU72-189 and MCU75-185 (Lee et al., 2015)

While I was performing structural-rationalized mutations based on my own crystal
structures discussed in this thesis, a structural study on MCU residues 75-185 was
published, showing a similar overall fold to my MCU72-189 protein (Figure 4.1). However,
despite the similarities of the fold, there are two prominent differences. First, my
MCU72-189 protein shows a dynamic C-terminal tail (i.e. residues 168-189) that cannot be
modeled in the electron density. Lee et al., (Lee et al., 2015) found that the position of this
C-terminus region (i.e. residues 166-185) can be stabilized by a tetraethylene glycol
molecule, revealing a third α-helix close to α2 (Figure 4.1). Considering the mobility of the
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C-terminal tail and its close proximity to the MCU acidic patch, residues 168-189 could act
as a dynamic cap, involved in regulating the accessibility of cations and/or other larger
molecules. The second difference involves the formation of the R93:E95 salt bridge.
Although this salt bridge may stabilize the conformation of L2, it appears to be less
favorable in the Lee et al., (Lee et al., 2015) structure (i.e. NH1:O distances of 2.9 Å in
the present work versus 5.1 Å) (Figure 4.1). It is interesting that S92 is a proposed
phosphorylation site very close to the salt bridge found in my structure, and its mutation
results in suppression of MCU activity (Lee et al., 2015). Phosphorylation of S92 is
important as it induces conformational changes by breaking the hydrogen bonds in the L2
and L4 loops and modulating MCU function (Joiner et al., 2012; Lee et al., 2015; Settimo
et al., 2007). Therefore, the R93:E95 salt bridge may play an important role in regulating
the phosphorylation event that modulates MCU function.
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Figure 4.1. Ribbon view of the backbone alignments of MCU72-189 solved in the
presence of MgCl2 (green) and MCU75-185 (4XTB.pdb). The additional C-terminal
helix (α3) stabilized by tetraethylene glycol in the MCU75-185 structure is shown in
red. The differences in the L2 salt bridge residue orientation are highlighted with R93
residues (blue sticks) and E95 residues (red sticks). The salt bridge was identified
using ESBRI (Costantini et al., 2008), but not by the online tool used for the
MCU75-185 structure (Lee et al., 2015). The distance between the R93 and E95
residues for MCU72-189 is 2.9 Å, whereas the distance between the R93 and E95
residues for MCU75-185 is 5.1 Å. Structural alignments were performed with Theseus
(Theobald & Wuttke, 2008) between residues 75-167, common to both structures.

80

4.3

Significance of MCU in vitro and in vivo data

In vitro, the MCU72-189 matrix region binds the divalent cations Ca2+ and Mg2+ with ~mM
binding affinity in the acidic patch. Interestingly, Mg2+ is the most abundant intracellular
divalent cation, with cytosolic and nuclear concentrations maintained in the mM range
(Romani et al., 1993; Szanda et al., 2009). Mg2+ is known to enter the mitochondria
electrogenically through a high conductance Mg2+ channel known as the Mrs2p channel;
therefore, alterations in the mitochondrial membrane potential can modulate Mrs2pmediated Mg2+ uptake (Kolisek et al., 2003; Schindl et al., 2007; Zsurka et al., 2001). It is
also known that varying concentrations of PO43-, ADP and ATP can alter the free Mg2+
concentration in the mitochondrial matrix, which is ~0.5-1.5 mM (Gout et al., 2014; Jung
et al., 1990; Rutter et al., 1990). Therefore, under physiological conditions with saturation
levels dependent on the metabolic state of the cell, a large fraction of MCU molecules could
bind Mg2+. Additionally, Mg2+ is able to inhibit mitochondrial Ca2+ uptake (Favaron &
Bernardi, 1985; Jacobus et al., 1975; Prentki et al., 1983; Szanda et al., 2009), which can
even occur after elevations in cytosolic Mg2+ (Crompton et al., 1976; Saris et al., 2000;
Szanda et al., 2009). Consistent with this notion, it has also been found that matrix Mg2+
inhibits swelling and uncoupling of mitochondria associated with opening of the mPTP
caused by Ca2+ uptake during cell death (Bernardi et al., 1993; Novgorodov et al., 1994;
Saris et al., 2000; Zoratti & Szabo, 1995).
Although it is unlikely for global free Ca2+ levels to approach mM levels in the matrix, the
charge difference between the inside and outside of the matrix (-180 mV) is a massive
driving force for cations, which would reach mM levels if allowed to freely equilibrate.
Therefore, the highly negative mitochondrial membrane potential is the driving force
responsible for establishing Ca2+ levels within the mitochondrial matrix. According to the
diffusion theory, local Ca2+ levels would be in the mM range at the immediate base of the
channel pore (Bauer, 2001; Chad & Eckert, 1984; Simon & Llinas, 1985) and ~0.1 mM at
a distance of ~10 nm from the exiting region (Tadross et al., 2013). Therefore, the Ca2+
binding ability of MCU72-189 will be dependent on its proximity to the open pore.
Interestingly, it has been shown that sustained cytosolic Ca2+ levels inactivate the
mitochondrial Ca2+ uptake pathway (Moreau et al., 2006).
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To complement my in vitro studies, the Muniswamy Madesh group (Department of
Medicine, Temple University) performed functional studies on MCU in live HEK293T
cells. I have included this complementary work in the appendix of my thesis since the
mutations and rationale for these studies were based on my in vitro work described in this
thesis. The Madesh group observed that elevation of matrix Ca2+ inhibits the MCUdependent Ca2+ uptake rate without changes in the normal mitochondrial membrane
potential levels (App Fig. 1). The destabilization of MCU72-189 induced by Ca2+ binding
may be an important contributor to this inhibition and may be a protective buffering
mechanism to prevent cell death or damage induced by mitochondrial Ca2+ overload
(Giorgi et al., 2012). Further work by Muniswamy also revealed that D131A, D131R,
D147A and D147R substitutions attenuate Ca2+ uptake in live cells compared to native
MCU, without significant differences in the mitochondrial membrane potential (App Fig.
2-4). Specifically, HeLa cells overexpressing WT MCU showed a significantly increased
maximal mitochondrial Ca2+ uptake compared to empty vector transfected cells. On the
other hand, each of the mutants mentioned showed significantly reduced mitochondrial
Ca2+ uptake compared to endogenous MCU (i.e. D131A, D131R, D147A) and WT MCU
overexpression (i.e. D131A, D131R, D147A, D147R), hence revealing a dominantnegative effect for some of the mutants (App Fig. 2). HeLa cells expressing WT MCU
showed a significant decrease in agonist-induced cytosolic Ca2+ levels compared to empty
vector cells and all the mutants (App Fig. 4).
Taken together, my in vitro data complemented by the Madesh group live cell data reveal
that MCU can be self-regulated by mitochondrial Ca2+ and Mg2+ levels. I have shown that
when MCU72-189 binds Ca2+ or Mg2+, the protein is destabilized and its self-association
equilibrium is shifted toward monomer. These divalent cations bind on a distinct, acidic
patch, in which its mutation destabilizes MCU72-189 similar to cation binding and decreases
its sensitivity to Ca2+ and Mg2+. Additionally, incorporation of mutations in the acidic patch
causes monomerization and can attenuate MCU uptake in live cells in a dominant-negative
manner. Based on these observations, I propose a model of regulation in which MCU
activity is inhibited upon Mg2+ and/or Ca2+ binding to the MCU soluble matrix domain via
a destabilization that is associated with a suppression in self-association (Figure 4.2). In the
biological context, the metabolic state of the cell and the varying amounts of PO43-, ADP
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and ATP would modulate MCU activity. Additionally, the Mrs2p activity would also
modulate MCU activity, where increased free Mg2+ would inhibit MCU activity. An open
MCU pore resulting in high Ca2+ levels (i.e. ~mM) within nanodomains in close proximity
to MCU72-189 would also inhibit MCU activity in a negative feedback mechanism.
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Figure 4.2. Model of MCU autoregulation by Mg2+ and Ca2+. (A) MCU channel
activation by increased IMS Ca2+ levels. The dimerized MCU72-189 domain on the
matrix side of the channel is shown in ribbon view. (B) Feedback-inhibited MCU
channel due to self-association disruption by high Ca2+ levels in nanodomains close
to the channel pore. (C) Inhibited MCU channel due to increased free Mg2+ levels
entering the matrix through the Mrs2p channel. Mg2+ and Ca2+ are depicted as red and
orange spheres, respectively. Note that in (a) – (c), the precise stoichiometry of the
channel is not known, and known protein regulators that directly or indirectly interact
with MCU have been omitted for simplicity. In (b) – (c), the dimerized MCU72-189
ribbon structures are reduced to fit illustrations.
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4.4

Contrasting perspectives on MCU function and regulation

Recently, a paper that talks about matrix Ca2+ inhibiting MCU activity via EMRE has been
published (Vais et al., 2016). This proposed mechanism may be different than the
regulatory mechanism I am proposing, since my data suggests that Ca2+ binds directly to
MCU to inhibit its activity, whereas this paper states that inhibition of MCU activity by
Ca2+ is mediated by EMRE (Vais et al., 2016). It is important to note that the orientation of
EMRE described in this paper is different from the orientation of EMRE described in many
other recent papers. Vais et al., (Vais et al., 2016) state that the C-terminal of EMRE is
localized in the mitochondrial matrix, whereas other papers have stated that the C-terminal
of EMRE is localized in the IMS (Pendin et al., 2014; Sancak et al., 2013; Tomar et al.,
2016; Tsai et al., 2016; Yamamoto et al., 2016). Clearly, further studies need to be done to
have a better understanding of EMRE orientation and how it may be regulating MCU.
A separate group also had a paper recently published which describes a low resolution
solution nuclear magnetic resonance spectroscopy and EM structure of the pore domain of
MCU (Oxenoid et al., 2016). This paper states that MCU in the closed state oligomerizes
as a pentamer (Oxenoid et al., 2016). However, I believe that the pentamer is suspect in
this paper for two important reasons. First, when calculating the MW of MCU via SECMALS, they did not account for the bound micelle, hence overestimating the calculated
MW of MCU (Oxenoid et al., 2016). Second, the chemical crosslinking [i.e. using 3,3’dithiobis (sulfosuccinimidyl propionate)] and SDS-PAGE approach they used to further
characterize the MCU oligomerization state is highly ambiguous (Oxenoid et al., 2016).
Specifically, when visualizing the gel, the pentamer band shows little intensity whereas the
monomer and dimer bands have the strongest intensity (i.e. ~75% of the intensity) (Oxenoid
et al., 2016), indicating that most of MCU is oligomerized as monomer and dimer,
consistent with my data. Therefore, I am skeptical of the notion that MCU oligomerizes as
a pentamer. However, the work does suggest a role for the C-terminal domain in MCU
oligomerization, and clearly, further structural work is required on the full-length molecule
to reveal the precise functional MCU oligomerization state.
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4.5

Conclusion

In conclusion, my structural and in vitro data of MCU72-189 suggest that MCU is
autoregulated by Ca2+ and/or Mg2+ that bind to an acidic patch, destabilizing the selfassociation of the soluble matrix region of MCU. In fact, this regulatory model is consistent
with a recent study that showed inhibition of MCU by Mg2+ (Blomeyer et al., 2016), as
well as a study that showed Ca2+-dependent inactivation of mitochondrial Ca2+ uptake
(Moreau et al., 2006). However, further work needs to be done to determine if the acidic
patch is involved in modulating MCU activity through protein-protein interactions. Future
structural studies would involve the associated regulators of MCU (Section 1.7) to expand
our knowledge on the function and modulation of MCU activity. Important structural
studies would involve performing pull-down experiments, nuclear magnetic resonance or
intrinsic fluorescence to evaluate the interactions between MCU and the MICU1 domains,
as well as the EMRE domains. Since there has been debate over the interactions of MICU1
and EMRE with MCU (Foskett & Madesh, 2014; Perocchi et al., 2010; Sancak et al., 2013),
these interactions could be tested to help further clarify the interactive role of MICU1 and
EMRE in modulating MCU function. Nonetheless, my findings provide new mechanistic
insights into MCU regulation and lay the foundation to the future design of MCU inhibitors
to control cell death and treat a range of Ca2+-related pathological processes.
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Appendix Figure 1. Ca2+-dependent MCU inactivation in live cells. Digitoninpermeabilized HEK293T cells bathed in intracellular-like solution containing
thapsigargin were loaded with the Ca2+ indicator dye Fura2FF (1M), to which
pulses of 10 M extracellular Ca2+ were delivered before the addition of the
mitochondrial uncoupler CCCP (2 M) (arrowheads). Changes in bath Ca2+ (Ca2+out)
were measured in the absence and presence of the NCLX blocker, CGP37157
(10 M). (A) Representative traces of [Ca2+]out from three independent experiments.
(B) Quantification of [Ca2+]m uptake rate taken from the reduction in bath Ca2+ after
30 M [Ca2+]out addition. Error bars represent SEM. **P<0.01.
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Appendix Figure 2. Live cell MCU functional activity. HeLa cells were transiently
transfected with genetically encoded Ca2+ sensors (mito-R-GECO1 or cytosolic-RGECO1), which are mitochondrial and cytosolic Ca2+ indicators, respectively, along
with empty vector, MCU-WT-GFP, MCU D131A-GFP, MCU D131R-GFP, MCU
D147A-GFP, or MCU D147R-GFP. HeLa cells were stimulated with 100 M
histamine after one minute baseline recording. (A) Representative mean traces of
mito-R-GECO1 fluorescence (f.a.u.) in HeLa cells transfected with empty vector
(grey), MCU-WT-GFP (green), MCU D131A-GFP (pink), MCU D131R-GFP (blue),
MCU D147A-GFP (yellow), and MCU D147R-GFP (red). (B) Quantification of peak
mito-R-GECO1 fluorescence (Fmax/F0) (mean ± s.e.m). *P <0.05; **P <0.01; ***P
<0.001.
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Appendix Figure 3. Mitochondrial membrane potential of HeLa cells. HeLa cells
were transiently transfected with genetically encoded Ca2+ sensors (mito-R-GECO1
or cytosolic-R-GECO1), which are mitochondrial and cytosolic Ca2+ indicators,
respectively, along with empty vector, MCU-WT-GFP, MCU D131A-GFP, MCU
D131R-GFP, MCU D147A-GFP, or MCU D147R-GFP. (A) HeLa cells were
stimulated with 100 M histamine after one minute baseline recording. 48 hours
post-transfection, cells were loaded with the mitochondrial membrane potential
(DYm) indicator TMRM (50 nM). After baseline recording, the mitochondrial
uncoupler CCCP (10 M) was added. (B) Quantification of TMRM fluorescence.
(mean ± s.e.m). ns, not significant.
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Appendix Figure 4. Live cell MCU functional activity. HeLa cells were transiently
transfected with genetically encoded Ca2+ sensors (mito-R-GECO1 or cytosolic-RGECO1), which are mitochondrial and cytosolic Ca2+ indicators, respectively, along
with empty vector, MCU-WT-GFP, MCU D131A-GFP, MCU D131R-GFP, MCU
D147A-GFP, or MCU D147R-GFP. HeLa cells were stimulated with 100 M
histamine after one minute baseline recording. (A) Representative mean traces of
cytosolic-R-GECO1 fluorescence (f.a.u) in HeLa cells transfected with empty vector
(grey), MCU-WT-GFP (green), MCU D131A-GFP (pink), MCU D131R-GFP (blue),
MCU D147A-GFP (yellow), and MCU D147R-GFP (red). (B) Quantification of
cytosolic Ca2+ elevation as a function of R-GECO1 fluorescence (F-F0/F0) (mean ±
s.e.m). *P <0.05.
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